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HEADACHES: PATHOGENETIC ASPECTS
EFFECT OF NITROGLYCERIN ON TEMPORAL SUMMATION
THRESHOLD OF NOCICEPTIVE FLEXION REFLEX IN
MIGRAINE PATIENTS
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Background and aims In migraineurs, nitroglycerin (NTG) induces
severe delayed headache, resembling spontaneous migraine attacks.
The temporal summation threshold (TST) of the nociceptive flexion
reflex (NFR) is considered an objective method that offers the poten-
tial to examine pain processing in the central nervous system. The aim
of the present study was to evaluate the NFR-TST during NTG-
induced migraine. 
Methods Twenty-nine patients (19 females and 10 males, mean age
36.2±7.67, range 18–55 years), suffering from migraine without aura
(1.1 ICHD-II, 2004) were selected. Headache was induced by sublin-
gual administration of 0.9 mg of NTG. NFR-TST and the subjective
painful sensation were measured before and 30, 60, 120 and 240 min
after drug administration.
Results All patients exhibited a significant (p<0.01) reduction of the
NFR-TST 120 min after drug administration. In particular, a sub-group
of patients experiencing severe attack showed a significant (p<0.01)
reduction of NFR-TST at both 60 and 120 minutes.
Conclusions NTG appears to support a reliable experimental model of
migraine, based on the neuronal effects on the integrative-nociceptive
structures. The NFR-TST facilitation during NTG-induced attack
reflects an extracephalic generalized hypersensitivity of pain pathways
during migraine attack that provides the susceptibility for triggering
migraine attack and probably its persistence.
CAN HIGH-FREQUENCY rTMS RESTORE NORMAL INTRA-
CORTICAL EXCITABILITY IN MIGRAINE WITH AURA?
EFFECTS OF PRIMING STIMULATION ON 1 HZ rTMS
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Introduction We showed that motor intracortical inhibition (ICI) is
reduced in patients affected by migraine with aura. Consequently, 1 Hz
rTMS-induced paradoxical effects increase motor intracortical facilita-
tion (ICF) in these patients. In conditions of enhanced excitability due
to reduced inhibition, high frequency rTMS acts by potentiating intra-
cortical inhibition [1, 2].
On this basis, we used high frequency priming stimulation of the motor
cortex to enhance intracortical inhibition and reverse paradoxical facil-
itation induced by 1 Hz rTMS in migraine with aura patients. To dif-
ferentiate the possible different effects on ICF or ICI, we applied the
double-pulse TMS technique that allows evaluation of the intracortical
circuits.
Methods Seven patients with migraine with aura and six controls
underwent a paired-pulse TMS paradigm to evaluate ICI and ICF of the
motor cortex before and after a conditioning high frequency rTMS fol-
lowed by 1 Hz rTMS train. Patients were examined interictally at least
48 h before or after an attack. The hot-spot for the right abductor pol-
licis brevis (ABP) was checked by mean of a figure-of-eight coil and
motor threshold (MT) on this recorded point. ICI and ICF were
assessed by means of a conditioning stimulus (CS) at 80% MT fol-
lowed by a test stimulus (TS) at 120% MT, with two different inter-
stimulus intervals: inhibitory: 2 msec and facilitatory 10 msec. Priming
rTMS (900 stimuli at 10 Hz frequency, in trains of 50 stimuli separat-
ed by 45 s intervals) was followed by a single 15-min-long train (900
stimuli) at 1 Hz rTMS. rTMS was delivered at 90% of MT over the hot-
spot. Motor evoked potential (MEP) amplitude of TS post-rTMS was
expressed as percentage of baseline MEP. Amplitude of MEPs record-
ed at 2 and 10 ms ISIs before and after rTMS were expressed as per-
centage of change from the respective mean TS alone. 
Results At baseline, ICI was significantly lower in migraineurs with
respect to controls. In healthy controls, MEP amplitude and ICF were
significantly reduced by priming 1 Hz treatment with respect to base-
line values. In contrast, the priming stimulation significantly increased
ICI in migraineurs, leaving quite unchanged MEP amplitude and ICF
values with respect to baseline.
Conclusions In migraineurs, rTMS-priming potentiates intracortical
inhibition and reverses the paradoxical increase in ICF observed with
1 Hz rTMS [1]. These findings strengthen the hypothesis of reduced
inhibition in migraine with aura and might open perspectives for new
treatment strategies.
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EFFECTS OF REMOTE CUTANEOUS PAIN ON TRIGEMINAL
LASER EVOKED POTENTIALS IN NORMAL SUBJECTS AND
MIGRAINE PATIENTS
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Introduction In a previous study a different modulation of trigeminal
laser evoked potentials (LEPs) was detected in migraine patients vs
controls during topical application of capsaicin on the supraorbital
skin. The inhibiting central effect exerted in controls by capsaicin on
trigeminal LEPs was less evident in migraine, suggesting a disturbed
pattern of pain modulation at the cortical level, which may subtend the
onset and persistence of migraine [1].
Objective The aim of the present study was to detect the functional
changes of trigeminal LEPs during topical application of capsaicin
over a remote site of the body in migraine patients outside the attacks
vs. non migraine healthy controls.
Methods Ten patients suffering from migraine without aura (ICHD-II,
2004), free from pain and symptomatic drugs for at least 72 hours and
not taking preventive treatment for migraine were selected for the
study. Eight age- and sex-matched healthy controls were also exam-
ined. LEPs were recorded by 31 scalp electrodes, referred to the
nasion, stimulating the dorsum of the right hand and the right supraor-
bital zone in basal conditions and 30 minutes after application of 3 mL
of 3% capsaicin in a cream base (Teofarma), which was applied topi-
cally on the entire surface of the dorsum of the left hand, within an area
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of at least 6 cm2. The subjective pain induced by both laser stimulus
and capsaicin was rated by a 0–100 visual analogue scale (VAS).
Results In normal subjects, the N2-P2 vertex complex showed
32.3%±3.4% rate of amplitude reduction at the trigeminal level and
30.2%±7.8% at the hand level, caused by remote capsaicin application.
In migraine, the rate of N2-P2 amplitude reduction at the hand level
was similar to controls (31.3±9.8; F=0.67, n.s), while it was signifi-
cantly lower at the face level (2.1%±4.5% F=16.5, p<0.001). The N1
amplitude was not significantly modified by capsaicin, when both the
face and the hand were stimulated. N2-P2 amplitude modifications
were reversed after capsaicin removal in both patients and controls.
Discussion The N2-P2 amplitude reduction induced in normal sub-
jects at both the hand and face levels could be due to a diffuse nox-
ious inhibitory control and to the distraction induced on LEPs by
concurrent capsaicin-induced pain. Both the pain-inhibiting mecha-
nisms appeared inadequate in reducing experimental trigeminal pain
in migraine patients.
Conclusions In migraine patients trigeminal pain is not inhibited by
the anti-nociceptive endogenous control system.
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Introduction Primary headaches have an intimate relationship with
sleep. Although strictly sleep-related headaches, such as hypoxemia-
related headache, cluster headache (CH) and hypnic headache (HH) are
less prevalent and more easily recognized, other primary headaches are
often impacted to some degree by sleep.
Objective The aim of the study was to describe the results of sleep
studies performed in different forms of primary headache and their
pathophysiological correlates.
Methods Patients underwent a full-night laboratory nocturnal video-
polysomnography following adaptation. Patients slept in a sound-proof
room. A wrist actigraphic study was also performed in patients with
HH and CH.
Results Hypnic Headache: The most relevant finding regarding sleep
structure was the quantitative reduction of rapid eye movement (REM)
sleep. Actigraphic recordings showed that the index of motor activity
was consistently increased following the start of effective drug treat-
ment. This might constitute further support for the hypothesis of
hypoarousal as a pathogenic mechanism for HH.
Cluster Headache: No modifications of polysomnographic arousal
parameters across the recordings were observed in the acute phase,
when compared with the interictal phase, except for the arousal index
in REM sleep. At a microstructural level, the arousal index calculated
in REM was much lower in the nights in which attacks occurred.
Actigraphic recordings revealed, moreover, that the patient’s sleep-
wake schedule was irregular during the CH period and progressively
modified, becoming more regular after remission. All the observed
modifications are consistent with an abnormal function of the posteri-
or hypothalamus.
Sleep-related migraine: Evaluation of the pattern of arousal from sleep
in a group of patients affected by sleep-related migraine showed a
lower continuous airway pressure (CAP) rate in non REM sleep and,
in particular, a lower number of A1 phases (low-frequency, high-ampli-
tude EEG bursts) compared with controls. Migraineurs also showed a
lower index of high-frequency EEG arousals during REM sleep.
Reduction in the CAP rate indicates a lower level of arousal fluctuation
in non REM sleep. The reduced arousal index in REM sleep suggests
a dysfunction in neural structures involved in both the control of REM
sleep and the pathophysiology of migraine, such as the hypothalamus
and the brainstem.
Conclusions We believe that sleep studies, including both macro- and
microstrucural analysis of sleep and actigraphy, may be useful in clar-
ifying the pathogenic mechanisms of primary headaches.
DESTABILIZING CONDITIONS IN MIGRAINE PATIENTS
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Objective The aim of this study was to assess the presence of destabi-
lizing inputs that, by acting on vestibulospinal pathways, are able to
induce postural changes and imbalance conditions in migraine patients
during the interictal period, by computerized static stabilometry.
Material and methods Twenty patients were studied (14 F and 6 M;
mean age 32.6 years) affected by migraine without aura (MO)
according to ICHD-II, 2004 criteria and were compared with 35 con-
trols. The stabilometric parameters considered were: statokinesigram
surface (S) in eyes open (EO) and closed (EC) conditions, EC with
head retroflexion (ECR), EC condition with occlusal bite, and opto-
kinetic stimulation (OKN). Regarding the OKN condition, we used
two different kinds of stimulation: the “look” (active) type, in which
the patient must follow with the eyes the visual stimulation running
through the monitor, and the “stare” (passive) type, in which the
patient must look at a fixed point on the monitor and not the visual
stimulation crossing the monitor.
Results We found a significant statistical difference (p<0.045)
between patients and controls in only one stabilometric condition, the
OKN stimulation. In particular, the OKN “stare” stimulation was
more destabilizing for migraine patients than for controls, inducing
conditions of imbalance.
Conclusions In MO patients, the alterations appear under optokinetic
stimulation and support a control impairment in involuntary oculo-
motility of central origin. This is suggested by recent stabilometric
findings of our group [1].
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Introduction Some studies suggested that migraine is associated with
an impaired activity of the autonomic nervous system [1]. It is known
that the subject with migraine has a reduction in R-R intervals and a
reduction in the increase of the heart rate during “handgrip” in com-
parison with the control group [2].
Objective The objective of our study was to analyse in subjects with
migraine with aura the heart rate variability (HRV), evaluated in time
and frequency domains by means of ECG holter during 24 hours.
Patients and methods We recruited subjects with migraine with aura
during headache-free periods, without treatment. The control group
consisted of age- and sex-matched healthy control subjects.
Autonomic nervous system function was evaluated by HRV analysis
during 24-hour ECG recording, SDNN (millisec, total autonomic
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activity), RMS-SD (millisec parasympathetic component), low fre-
quency (LF, modulated by the sympathetic system) and high fre-
quency (HF, mediated by the parasympathetic system) were calculat-
ed. The day was divided into two periods: diurnal (7–12 a.m.) and
nocturnal (0–6 a.m.).
Results Autonomic function measures: SDNN day (millisec): migraine
146.16±28.41, control 175.92±30.13, p=0.38; SDNN night: migraine
116.26±22.23, control 121.98±26.59, p=0.63; RMS-SD day:
121.98±26.59, control 121.98±26.59, p<0.001; RSM-SD night:
migraine 48.19±15.28, control 48.19±15.28, p=0.75; LF day (normal-
ized unit): migraine 61.20±2.27, control 69.90±8.34, p=0.003; HF day:
migraine 38.80±2.27, control 22.95±7.31, p=0.002; LF night: migraine
55.13±10.72, control 34.92±5.99, p=0.03; HF night: migraine
44.95±10.69, control 58.62±6.77, p=0.03.
Conclusions In subjects with migraine, the data showed the increase
of parasympathetic activity during the day and the predominance of
the sympathetic component at night with loss of circadian rhythms.
It remains unclear if the alteration of the autonomic nervous system
is a risk factor for migraine, or instead, is a consequence of the
pathology.
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Background Recently, studies using FDG-PET techniques have
reported hypoactivation of nuclei belonging to the “pain network” in
patients with medication-overuse headache (MOH). In particular, it
has been shown that the ventral posteromedial thalamic nuclei were
hypometabolic in migraineurs suffering from MOH [1]. Since the
high-frequency oscillations (HFOs) embedded in the common
somatosensory evoked potentials (SSEPs) recording reflect spike
activity in thalamo-cortical cholinergic fibers (early HFOs phase) and
cortical inhibitory GABA-ergic interneurons (late HFOs phase), we
studied a group of MOH patients with this neurophysiological
approach.
Materials and methods Right median nerve SSEPs were recorded
from the contralateral parietal area in 9 patients affected by medica-
tion-overuse headache (MOH, ICHD-II 8.2) and in 9 healthy volun-
teers (HV). Digital off-line filtration (band-pass between 450 and 750
Hz) was employed in order to extract the high frequency (600 Hz)
oscillations embedded in the broad-band SSEPs.
Results The amplitudes and latencies of conventional broad-band
SSEPs showed no between-group differences. After applying the digi-
tal filter, we found a significant decrease of maximal amplitude
(p=0.030) and area under the rectified curve (p=0.038) of the early
SSEP HFO component in patients compared to HV. By contrast, no dif-
ference was found for the late SSEP HFO component.
Discussion These results show thalamo-cortical hypoactivity in
patients with MOH. This is in line with the previous FDG-PET study
showing thalamic hypometabolism. The absence of SSEP HFO late
component changes suggests normal intracortical inhibition at the level
of the somatosensory cortex in this patient group.
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INCREASED CEREBROSPINAL FLUID LEVELS OF NERVE
GROWTH FACTOR AND BRAIN-DERIVED NEUROTROPHIC
FACTOR ARE NOT SPECIFIC FOR CHRONIC MIGRAINE:
COMPARISON WITH FIBROMYALGIA
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Background Experimental findings from animal pain models support
the role of nerve growth factor (NGF) and brain-derived neurotrophic
factor (BDNF) as putative candidates intervening in the pathogenesis
of chronic pain. Few studies have been carried out to establish their
role in maintaining the pain states in humans and their involvement in
chronic migraine (CM) and fibromyalgia [1, 2].
Objective The present study was aimed at investigating cerebrospinal
fluid (CSF) levels of NGF and glutamate measured by sensitive
immunoassay and by HPLC respectively in CM patients and patients
affected by primary fibromyalgia syndrome (PFMS), comparing values
with those of 20 age-matched control subjects.
Material and methods Twenty consecutive patients suffering from
CM according to ICHD-II classification and attending the Headache
Centre of the Neurologic Clinic of the University of Perugia were
admitted to the study.
A further patient group included 20 patients affected by PFMS.
Diagnosis of PFMS was made according to the American College of
Rheumatology Criteria (1990).
All patients were admitted to the Neurologic Clinic to undergo lumbar
puncture. Control CSF specimens were obtained from 20 age-matched
subjects who underwent lumbar puncture for diagnostic purposes. In all
subjects CSF and blood tests excluded CNS or systemic diseases. All con-
trol subjects were drug-free for at least two months and none of them were
taking any medication at the time of CSF sampling nor had a personal or
family history of migraine nor suffered from tension-type headache. None
of the above controls developed post-lumbar puncture headache.
Results Significantly higher levels of both neurotrophins were found
both in patients with CM (p<0.0001, p<0.0005) and PFMS (p<0.001
and p<0.001) compared with control subjects, without significant dif-
ferences between the two patient groups. Both patient groups had sig-
nificantly higher CSF levels of glutamate than controls (p<0.001 and
p<0.003, respectively). A significantly positive correlation emerged
between CSF values of BDNF and those of NGF (r=0.61, p<0.001;
r=0.53, p<0.01) and glutamate (r=0.44, p<0.02; r=0.51, p<0.01) in
both CM and PFMS patients, respectively.
Conclusions These findings suggest the possibility of an NGF-mediat-
ed up-regulation of BDNF in central sites involved in long-term sensi-
tization, which plays a key role in persistent, chronic painful condi-
tions, such as CM and fibromyalgia. NGF might indirectly exert its
effect through enhancement of glutamatergic transmission via BDNF.
The above mechanisms could account for sustained central sensitiza-
tion in both chronic pain states but cannot be considered specific for
just one of these two disorders. They may rather be considered expres-
sion of the pathogenic mechanisms underlying chronic pain per se.
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ENDOCANNABINOIDS IN PLATELETS OF MEDICATION-
OVERUSE HEADACHE PATIENTS AND CHRONIC MIGRAINE
PATIENTS: CORRELATION WITH SEROTONIN LEVELS
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Background Based on experimental evidence of the antinociceptive
action of endocannabinoids [1], we hypothesized a dysfunction of this sys-
tem in medication-overuse headache (MOH) and chronic migraine (CM).
Objective To test this hypothesis, we determined the levels of the
endogenous cannabinoid 2-arachidonoylglycerol (2-AG) and arachi-
donoylethanolamide (anandamide, AEA) in platelets of 15 patients
affected by MOH according to ICHD-II and 15 patients with CM with-
out medication overuse, as well in 15 age-matched control subjects. We
also investigated the intra-platelet levels of serotonin.
Methods Endogenous cannabinoids were purified from platelet pellets
by high-performance liquid chromatography (HPLC), and quantified
by isotope dilution gas-chromatography/mass-spectrometry. Serotonin
levels were also measured by HPLC.
Results In both patients and controls levels of 2-AG were about 20-
fold greater than that of AEA. 2-AG and AEA levels were signifi-
cantly lower in medication overuse and CM patients than in controls
(p<0.02 and p<0.04, respectively), without significant differences
between the two groups. Serotonin levels were strongly reduced in
both patient groups (p<0.001 and p<0.002, respectively) and were
significantly correlated with 2-AG and serotonin levels (r=0.48,
p<0.01 and r=0.46, p<0.02).
Conclusions The finding of reduced 2-AG and AEA in platelets corre-
lated with reduced serotonin levels may reflect an imbalance in the
endocannabinoid system, which occurs in parallel with serotonergic
dysfunction in these two chronic head pain conditions. The parallelism
in the failure of these two systems is in line with experimental findings
of mutual interaction of 2-AG and 5-HT in modulating different sig-
nalling pathways, which can also be relevant for pain control.
Variations in activity of AEA transporter and AEA hydrolase in periph-
eral platelets, as recently shown in female but not male migraineurs
[2], remain to be established in MOH and CM.
This study has been partially supported by the Lega Italiana
Cefalalgici.
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Introduction The wolframin gene (WFS1) is mentioned as being possi-
bly responsible for a heterogeneous combination of psychiatric disorders;
in a number of studies it has been suggested that common variants in
WFS1 are associated with psychiatric illnesses. For instance, homozygous
carriers of the His611Arg polymorphism (R/R genotype) are at increased
risk of attempted suicide and generally score higher than non-R/R indi-
viduals on both novelty seeking (NS), impulsivity and depression scales.
It is well known that psychiatric comorbidity is widely represented in
medication-overuse headache (MOH). In the present study we investigat-
ed the wolframin His611Arg polymorphism in a sample of MOH patients
who submitted to psychiatric, psychometric and clinical assessment.
Materials and methods Fifty-two consecutive, unrelated MOH
patients (42 women and 10 men) were recruited. Mean age was
46.37±11.35 years; mean analgesic-drug consumption was 44.81±28.24
doses/month. All the patients were interviewed using the Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID-I), to obtain a
categorical psychiatric diagnosis, and completed the Beck Depression
Inventory (BDI), a self-reported questionnaire for a dimensional assess-
ment of depressive symptoms. The BDI mean score was 13.15±10.01.
Thirty-seven lifetime and 36 current psychiatric disorders were diag-
nosed. After obtaining the patients’ written informed consent, the geno-
type for the wolframin His611Arg polymorphism was determined.
Results R/R genotype carriers (10 patients) showed significantly high-
er drug consumption (62.3±35.35 vs. 40.64±25.00 doses/month;
t=2.266, p=0.028) and more severe depressive symptoms on the BDI
questionnaire (19.40±10.57 vs. 11.66±9.40; t=2.285, p=0.026) than
non-R/R individuals (42 patients). No significant correlation was
found between monthly drug consumption and depression score in our
MOH patients (r=0.137, p=0.334), even when their genotype was con-
sidered (R/R r=0.172, p=0.635; non-R/R r=0.004, p=0.979).
Discussion Even if it has been reported that depression predicts dis-
ability and increased drug consumption in headache patients, in our
MOH patients we found no direct correlation between depression
scores and monthly intake of analgesic drugs. We believe that the
increased drug consumption observed in R/R carriers is a consequence
of increased impulsivity and NS traits, irrespective of depression.
Conclusions WFS1 R/R genotype appears to be an aggravating factor
in drug overuse in MOH patients.
HEADACHES: CLINICAL ASPECTS
ANALYSIS OF PATIENTS ATTENDING A SPECIALIZED
HEADACHE CENTRE OF THE CALABRIA REGION OVER A
ONE-YEAR PERIOD
1R. Iannacchero, 2V. Rispoli, 1E. De Caro
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Objective Our aim was to analyse the diagnosis, prescribed medica-
tions and examinations conducted on patients attending a specialized
Headache Centre of the Calabria Region over a one-year period.
Methods An audit of clinical records of patients attending the
Headache Centre of the “Pugliese-Ciaccio” Hospital in Catanzaro,
from January 2005 to January 2006, was conducted. Data regarding
diagnosis, current medications, prescribed medications, and examina-
tions conducted were collected.
Results Four hundred and fifteen patients attended the clinic during the
audit period. Two hundred (48%) of them were diagnosed with chron-
ic daily headache (CDH), 160 (39%) with migraine, 32 (8%) with clus-
ter headache, and 19 (5%) with neuralgia headache TACs. All other
diagnoses involved only one patient (<1%) in each case. Most common
medications used by patients with CDH at the time of initial consulta-
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tion were: analgesics (64%), prophylactic drugs (17%), triptans (14%),
and diazepam (3%). Following the consultation, prophylaxis was pre-
scribed for 51% of patients while triptans for only 1%. At the time of
initial consultation, patients with migraine were taking: analgesics
(59%), triptans (26%), prophylactic drugs (19%), and ergotamine
(2%). Following the consultation, prophylactic drugs was recommend-
ed for 75% of patients, triptans for 49%, manipulation for 13%, and
analgesics for only 10%. Examinations were arranged for 19 patients
(9%) and were negative in all cases.
Conclusions Most patients attending our headache centre were suffer-
ing from CDH or migraine. Cluster headache was rarely diagnosed.
Despite this being a secondary care clinic, most patients were taking
analgesics and relatively few specific acute therapies or prophylactic
drugs. In contrast, triptan consumption markedly increased following
consultation. In all clinical cases, further examinations were negative
and were primarily conducted to reassure the patients.
A VALIDATION STUDY OF AN ITALIAN VERSION OF THE
“ID MIGRAINE”
1F. Brighina, 1G. Salemi, 1B. Fierro, 2A. Gasparro, 3A. Balletta, 
3A. Aloisio, 4G.B. La Pegna, 5G. Randisi, 6V. Saporito, 7G. Calagna, 
8F. Lanaia, 8R. Morana
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Introduction Migraine is a highly prevalent and disabling disease that
is substantially underdiagnosed in primary care. Recently, the ID
Migraine, a self-administered questionnaire, consisting of only three
items, was shown to be a valid and reliable screening instrument for
migraine in primary care in the U.S.A. The aim of the present study
was to validate an Italian version of the “ID Migraine” questionnaire.
Methods A total of 222 consecutive headache patients referring to eight
headache centres in Sicily (Italy) completed an Italian version of the ID
Migraine. The responses to the questionnaire were compared with the
diagnosis of headache made by a headache specialist who did not know
the results of the questionnaire. Sensitivity, specificity, positive and neg-
ative predictive value and accuracy level for migraine were calculated.
Results The statistical analysis on 222 patients examined showed a
very good performance of the ID Migraine with high sensitivity: 0.95
(95% CI, 0.91–0.98), specificity: 0.72 (95% CI, 0.62–0.82) and posi-
tive predictive value: 0.88 (95% CI, 0.82–0.93). ID migraine also
showed a very good accuracy level: 0.87 (95% CI, 0.83–0.92).
Conclusions This study demonstrated “ID Migraine” to be a valid tool
for migraine screening also in Italian patients referring to headache
centres. If confirmed in a primary care setting, these results would
establish the “ID Migraine” as a valid screening instrument for
migraine in the Italian population.
PATIENT COMPLIANCE TO COMPILATION OF THE
HEADACHE DIARY
L. Savi, P. De Martino, E. Zampella, L. Pinessi
Headache Centre, Neurology II, Department of Neurosciences,
University of Turin, San Giovanni Battista Hospital, Turin, Italy; 
e-mail: lsavi@molinette.piemonte.it
Introduction One of the most important tools in the approach to a
headache patient is the headache diary, whose compilation is a funda-
mental step in the formulation of the definitive diagnosis and in the
organization of a therapy, which must be appropriate to the individual
patient. The Headache Centre of the University of Turin began many
years ago to use such a diary which, though modified and improved in
the course of time, is still fundamentally the same.
Objective The purpose of this study was to evaluate the patient com-
pliance to the compilation of the headache diary.
Materials and methods A total of 575 patients (133 males and 442
females, age range 18–85 years) attending for the first time the
Headache Centre of the University of Turin in the period January 1 -
December 31, 2004, were enrolled in the study. They all suffered from
various kinds of primary headache diagnosed according to the
International Headache Society criteria (ICHD-II).
The usual diagnostic approach to the patients at the Headache Centre
of the University of Turin starts with a first visit, in the course of which
as much information as possible is collected from the patient’s inter-
view, and a symptomatic therapy is suggested. This is followed after
three months by a second visit, when a more definitive diagnosis is for-
mulated and, if it is deemed necessary, prophylactic therapy is sug-
gested to the patient. 
The patients are given the headache diary at the first visit. They are
instructed how to complete it and are asked to be as careful as possible
in its compilation.
They have to record many different characteristics of their headache
(pain, duration, intensity, localization, aggravation by routine physical
activity, presence of other symptoms, and drugs used).
It was evaluated how the diary had been filled in by all the patients who
came to the second visit, considering their age, level of instruction,
type of work, and comprehension of the language.
Results After the first visit 393 patients came back, while 182 did not.
Among those who came back, 324 (82.45%) filled the diary complete-
ly, while the remaining 69 (17.55%) filled it in only partially or did not
fill it in at all.
Discussion and conclusions On the basis of these data it is possible to
affirm that the majority of patients showed a very satisfactory compli-
ance to the diary compilation.
PATIENT COMPLIANCE TO THE DIAGNOSTIC APPROACH
IN HEADACHE
L. Savi, P. De Martino, E. Zampella, L. Pinessi
Headache Centre, Neurology II, Department of Neurosciences,
University of Turin, San Giovanni Battista Hospital, Turin, Italy; 
e-mail: lsavi@molinette.piemonte.it
Introduction The usual diagnostic approach to the patients at the
Headache Centre of the University of Turin starts with an initial visit,
in the course of which as much information as possible is collected
from the patient’s interview, and a symptomatic therapy is suggested.
This is followed after three months by a second visit, when a more
definitive diagnosis is formulated and, if it is deemed necessary, pro-
phylactic therapy is suggested to the patient.
According to some critics, this diagnostic approach is too long, and the
patients do not like it. 
Objective The purpose of this study was to evaluate how many
patients do not come back for the second visit that forms the usual pat-
tern of our approach, and why they do not return, to clarify if this crit-
icism is correct.
Materials and methods A total of 575 patients (133 males and 442
females, age range 18–85 years), attending for the first time the
Headache Centre of the University of Turin in the period January 1 -
December 31, 2004, were enrolled in the study. All patients suffered
from various kinds of primary headache diagnosed according to the
International Headache Society criteria ICHD-II. It was determined if
they had returned for the second visit or not. All patients who did not
return were contacted by phone to explain their reasons.
Results After the first visit 393 (68.35%) patients returned, while 182
(31.65%) did not. The principal reasons for their not returning, as report-
ed by those same patients were: the therapy was effective at the first
attempt or viceversa; headache attacks reduced their number after the
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first visit; the diary compilation was too complicated (it was a very dif-
ficult task for the patients with chronic headache); the diary was a nui-
sance because the headache attacks were so few; the fee paid for the visit
was too high and the visit itself did not offer a solution to their problem;
and the patient did not like the doctor’s approach at the first visit.
Discussion and conclusions On the basis of these data it is possible to
note that the majority of the patients accept and understand this diag-
nostic approach, so the criticism towards it does not seem to be realis-
tic. Considering the most frequent motivations reported by the patients
who did not come back, it appears likely that providing more informa-
tion could improve the situation.
PREVALENCE OF ARTERIAL HYPERTENSION IN THE REL-
ATIVES OF MIGRAINE PATIENTS
1F. De Cesaris, 1U. Pietrini, 1B. Anselmi, 2A. Del Bene, 1E. Del Bene
1Headache Centre, Department of Internal Medicine and 2Department
of Neurological and Psychiatric Sciences, University of Florence,
Florence, Italy; e-mail: f.decesaris@dmi.unifi.it
Introduction Migraine and some cardiovascular disorders should have
common pathogenic mechanisms, and genetic factors should play an
important role in the possible development of migraine in a subject
with a positive gender for cardiovascular disorders [1]. Moreover, in
the clinical history of patients affected by migraine the presence of
arterial hypertension in their relatives is frequently observed.
Objective The aim of our study was to assess how common this phe-
nomenon is in a population of children and adults.
Materials and methods The study sample included 190 patients
affected by episodic migraine without aura (according to ICHD-II cri-
teria, 2004 [2]), without other forms of headache and without other
comorbidity. Seventy-four subjects (38.94%, 50 F, 24 M, age range
10–72 years, mean age 39.05 years – Group A) did not refer gender
positivity for arterial hypertension, while 116 (61.06%, 86 F, 30 M,
range 6–77 years, mean age 33.97 years – Group B) referred the pres-
ence of arterial hypertension in almost one relative of first (parents),
second (sister, brother, grandparents) or third degree (uncles or aunts).
Before the visit, a dedicated, specific and simple questionnaire was
given to the patient for compilation.
Results In Group B, 83 subjects referred the presence of arterial hyper-
tension in one or both first degree relatives, 76 in second (with or with-
out first) degree relatives, 20 in third (with or without second and first)
degree relatives. The mean number of attacks per month was 4.51 in
Group A and 5.49 in Group B.
Conclusions This study has two limitations, the small patient cohort
and the absence of a control group (without migraine). Nonetheless, we
can suppose that migraineurs have a remarkable prevalence of relatives
with arterial hypertension, according to previous studies, and that the
number of attacks seems to be higher in the group with gender positiv-
ity for arterial hypertension.
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FOOD INTOLERANCE IN MIGRAINE
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Objective Several factors can trigger migraine; among them, dietary
factors play a very important role in the onset of migraine attacks. The
aim of our study was to evaluate the incidence of food intolerances in
a group of migraineurs, by using the Cytotoxic test.
Materials and methods Thirty consecutive patients suffering from
migraine presenting to the Headache Centre of S. Luca Hospital, Vallo
della Lucania (SA) were examined. Twenty-three were women, mean
age was 28.2 years, range 13–47 years; 7 were men, mean age was
39.33 years, range 28–62 years. The Cytotoxic test is capable of identi-
fying the presence of specific food intolerances by observing the
appearance, the size, the shape or the integrity of leukocytes exposed to
extracted food antigens or other materials derived from specific foods.
Results An intolerance was found to: tyramine in 12 women (52.17%)
and 3 men (42.85%); milk, 3 women (13.05%); yeast, 4 women
(17.39%) and 1 man (14.28%); solanaceae, 4 women (17.39%) and 1
man (14.28%); coffee, 5 women (21.74%); cocoa, 5 women (21.74%);
tea, 2 women (8.69%); eggs, 1 woman (4.35%) and 1 man (14.28%);
pork, 1 woman (4.35%); and sugar, 1 woman (4.35%).
Conclusions Our study showed a high incidence of food intolerance in
migraineurs (in women more than in men). The dietary factors which
gave more significant results were tyramine, yeast, solanaceae, coffee
and cocoa. These results are in agreement with those of other studies
found in the literature, proposing tyramine, coffee and cocoa as very
important migraine-precipitating factors. Conversely, there is little evi-
dence of a comorbidity between migraine and intolerance to
solanaceae. For this reason, further studies are warranted to confirm
this hypothesis.
ALTERATIONS IN GLUCOSE-INSULIN METABOLISM IN
MIGRAINEURS: PROSPECTIVE STUDY ON THE CLINICAL
IMPACT OF DIET ON MIGRAINE SEVERITY AND META-
BOLIC DATA IN A MIGRAINEUR POPULATION – PRELIMI-
NARY RESULTS
1,2C. Cavestro, 3A. Rosatello, 4G.M. Micca, 1G. Asteggiano
1Department of Neurology and 2Headache Centre, “San Lazzaro”
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Introducion Migraine is characterized by a complex biochemical dys-
function attributed to a disorder of the trigeminal and hypothalamic path-
ways. Impairment of glucose and insulin metabolism has been reported in
migraine [1], and insulin alterations seem to be specific to migraineurs.
Objective The main aim was to verify if a proper diet, eventually asso-
ciated with a insulin-sensitizing drug where indicated, could modify
the headache severity together with the glucose-insulin metabolic alter-
ation in migraineurs who presented alterations in glucose-insulin
metabolism.
Patients and methods The study population included all migraineurs
consecutively seen at the headache centre of our hospital during a one-
year period; all the recruited people underwent a general blood test and
a standard oral glucose tolerance test (OGTT) after a 12-hour fasting
period, measuring levels of glucose and insulin. A daily fragmented
low-percentage carbohydrate diet was suggested to those patients who
showed an alteration in glucose and or insulin metabolism. Each
patient was followed-up during a 3–6 month period, and another stan-
dard OGTT was performed, following a 3–6 month period of diet after
a 12-hour fasting period, measuring levels of glucose and insulin.
Evaluation of headache severity was expressed in severity index, cal-
culated on the basis of number of days with headache and each day
headache severity in 1–3 severity scale (1 mild, 2 moderate, 3 severe).
Results In a 12-month period, we recruited 173 migraineurs (138
women, 35 men), 132 patients had a metabolic glucose-insulin alter-
ation (102 women, 30 men), and 41 patients had normal metabolic pro-
file. Until now, 64 patients have been followed-up for at least 3–6
months. Headache severity index of the studied population was 31
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(SD±27) before diet and 12 after diet (SD±21) (p<0.000). Fasting blood
glucose levels (FBG) and after OGTT (in mg/dL) were slighty lower
after dieting (before diet, FBG: 96, at 30 minutes: 143, at 60 minutes:
113, at 120 minutes: 93; after dieting, FBG: 99, at 30 minutes: 131, at
60 minutes: 104, at 120 minutes: 83; p<0.3). Migraineurs after dieting
presented significantly lower insulin levels at any time of the test, both
fasting and after glucose loading (before dieting, FBG: 10, at 30 min-
utes: 100, at 60 minutes: 99, at 120 minutes: 55; after dieting, FBG: 7,
at 30 minutes: 74, at 60 minutes: 75, at 120 minutes: 38; p<0.1).
Discussion and conclusions A daily fragmented low percentage carbo-
hydrate diet can be useful as migraine non-pharmacological therapy. A
clinically positive impact of diet correlates with glucose and even more
with insulin levels, both fasting and after glucose loading. High insulin
levels are recorded in migraineurs, and these data seem to be specific to
this headache type. These findings are in keeping with recent reports on
the effects of insulin on brain functions and lend support to the possible
involvement of insulin in the pathogenesis of migraine [2].
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POST-PRANDIAL MOTILITY INDEX IS SIGNIFICANTLY
REDUCED IN MIGRAINE PATIENTS WITH DYSPEPTIC
SYMPTOMS
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Background and aims We have recently shown that in patients with
migraine and dyspepsia the intake of a low-caloric low-fat meal
induces a significant reduction of post-prandial discomfort thresh-
olds. This abnormality is not evident in patients with functional dys-
pepsia, thus suggesting that post-prandial reduction of discomfort
thresholds may characterize migraine patients. As variations of gas-
tric motility index (MI) were described in a subset of dyspeptic
patients, the aim of this study was to evaluate whether abnormalities
of this parameter may have a role in the pathophysiology of dyspep-
tic symptoms in migraine patients.
Materials and methods Eighteen patients with migraine without aura,
diagnosed according to ICHD-II criteria and dyspeptic symptoms (11
F, mean age 32±5 years), 16 patients with functional dyspepsia, diag-
nosed according to Rome II criteria (10 F, mean age 39±5 years) and
16 healthy volunteers (HV) (9 F, mean age 28±6 years) underwent gas-
tric barostat test, which monitors gastric motor activity (contraction or
relaxation) as changes in intraballoon volume (reduction or increase,
respectively) at a constant intrabag pressure. After an overnight fast, a
double lumen polyvinyl tube with an adherent, infinitely compliant
plastic bag (1200 mL capacity), finely folded, was inserted into the
stomach through the mouth. The polyvinyl tube was connected to a
computer-driven programmable volume-displacement barostat device.
During the test we evaluated gastric accommodation reflex and phasic
contractility, quantified using MI during fasting and during the first and
second 30-min period after administration of a low-caloric liquid meal.
A baseline reconstruction was performed using a computerised algo-
rithm and MI was calculated as the area between the signal and the
baseline normalised over time.
Results Both in dyspeptic patients with migraine and without migraine,
the mean increase of post-prandial gastric volume was indicative of a
physiological accommodation. Fasting MI was similar in patients
(migraine 27.5±7.1 mL x min; dyspepsia 26.9±4.6 mL x min) and HV
(24.8±4.3 mL x min). On the contrary, during the first post-prandial 30-
min period, post-prandial MI was significantly reduced (p<0.003,
ANOVA) in patients with migraine (13.4±4.8 mL x min) than in HV
(19.6±6.6 mL x min) and in dyspeptic patients (22.6±7.4 mL x min).
Conclusions Our results show that patients with migraine and dyspep-
tic symptoms suffer from an alteration of post-prandial gastric sensori-
motor function. In addition to the previously shown post-prandial
hypersensitivity, a reduction of post-prandial MI is also present.
EPIGONE MIGRAINE VERTIGO (EMV): A LATE MIGRAINE
EQUIVALENT
1P. Pagnini, 1L. Verrecchia, 1B. Giannoni, 1P. Vannucchi, 2F. De Cesaris,
2E. Del Bene
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Introduction The term Migrainous Vertigo (MV) [1] describes all the
vertiginous and postural disturbances that are variably expressed by
migrainous subjects. In 1988, Pagnini [2] proposed a classification of
the vestibular symptoms in migraine using a specific criterion: the
temporal relationship between headache and vertigo. According to
this classification we can find two large groups of MV: the associated
and the equivalent. The first represents the vestibular disorder that
adds to headache. The second represents the vestibular crisis that sub-
stitutes the single spell of headache. The equivalent form can occur
before the onset of headaches (precocious equivalent). It could appear
during the headache period (intercritical equivalent), or it can develop
after the headache ceases (epigone equivalent). This study concerns
the latter form.
Subjects and methods In a clinical observation of 13 years at the
Audiological Clinic of the University of Florence, we studied 28
migrainous patients with some features of recurrent vestibular disor-
ders: they suffered from late vertigo with onset only after headache had
ceased; their vertigo was not specific for other recurrent otoneu-
ropathies; there were no specific radiological signs or blood risk fac-
tors. With a follow-up at least of two years, we studied this patient
group with audiovestibular and neurological examinations and imag-
ing, focusing on the characteristics of headache and vertigo and how
they interchanged between each other.
Results and discussion Females represented 82% of the study group,
mean age of headache onset was 18 years and for vertigo was 38 years.
Migraine without aura was present in 78% of patients, kinetosis in
78%. The vertigo described by the patients was variable: 64% of
patients referred exclusively rotatory crises (mean duration 15 hours);
14% described dizziness or postural instability (mean duration 73
hours); 22% suffered from a combination of these features. The
headache passed to vertigo with a free interval in 26% of patients. A
period of alternation of headache and vertigo was present in 29% of
patients. In 45% of patients headache passed directly into vertigo.
There were no specific signs from audiovestibular examination during
intercritical periods, but in 36% we found a vestibular hyperreflectivi-
ty during stimulation. We saw a specific highly repetitive behaviour for
this new entity: the response to migraine prophylaxis. Vertigo
improved in all patients, furthermore, full recovery from vestibular
symptoms was obtained in 68% of patients.
Conclusions With this clinical observational study, we attempted to char-
acterize a new clinical picture of migraine, the epigone migrainous verti-
go, which should be considered when considering vertigo in migraine.
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MUSCLE TENDERNESS IN CRANIOMANDIBULAR AND
CERVICAL REGIONS AND PSYCHOMETRIC CORRELATES
IN A POPULATION OF MIGRAINE PATIENTS WITH AND
WITHOUT CHRONIC TENSION-TYPE HEADACHE AND
HEALTHY CONTROLS
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Background A relationship has been shown between pericranial mus-
cle tenderness and psychiatric disorders in migraine patients. In partic-
ular, this association has been observed in patients with both migraine
and chronic tension-type headache (CTTH).
Objective The aim of the study was: 1) to evaluate the function of the
temporomandibular system and of the cervical spine in a population of
migraineurs with and without CTTH; 2) to evaluate the relationship
between muscle tenderness, personality profile and psychiatric symp-
toms in migraine patients with and without CTTH.
Materials and methods Migraineurs with and without CTTH were
consecutively recruited according to IHS criteria (ICHD-II). A healthy
control group was also recruited. All subjects of the study were sub-
mitted to: 1) clinical investigation of the temporomandibular system
according to the “Craniomandibular Index” (CMI); 2) pericranial mus-
cle evaluation according to “Total Tenderness Score” (TTS); 3) physi-
cal examination of the cervical spine (PECS); and 4) electrognathogra-
phy (EGG) of the temporomandibular joint. As regards personality pro-
file and psychiatric symptoms, the following tests were administered:
Tridimensional Personality Questionnaire (TPQ), Toronto Alexithymia
Scale – 20 items (TAS-20), State and Trait Anxiety Inventory (STAI-1-
2), and Beck Depression Inventory (BDI). All migraineurs underwent
Migraine Disability Assessment (MIDAS) and Headache Impact Test –
6 items (HIT-6) for evaluation of migraine disability.
Results Forty-two migraineurs (mean age 35±10 years), 35 migraineurs
with CTTH (mean age 34±12 years) and 32 healthy controls (mean age
32±11 years) were admitted to the study. All migraineurs showed sig-
nificantly higher scores in CMI, TTS and PECS than healthy controls
(p<0.05). Comparing EGG data between migraineurs and healthy con-
trols, we observed in the migraine population a reduction of mandibu-
lar movement associated with muscle rigidity (p<0.05). In regard to the
psychometric data, migraineurs showed higher scores in BDI and STAI,
Harm Avoidance dimension of the TPQ and TAS-20 than healthy con-
trols (p<0.05). All clinical and psychometric findings cited above were
more evident in migraineurs with CTTH than those without (p<0.05).
Duration of illness, frequency of attacks as well as MIDAS and HIT-6
scores were positively correlated with the total number of cran-
iomandibular and cervical tender points (p<0.05).
Conclusions Migraine patients present subclinical temporomandibular
and cervical spine disorders. These clinical findings are more evident
in migraineurs with CTTH and are associated with psychiatric symp-
toms and with a peculiar personality profile. It might be important to
identify these clinical features not only for the therapeutic implications
but also to prevent and understand the pathophysiological mechanisms
that may lead to chronic migraine.
MIGRAINE AS PRESENTING SYMPTOM OF CEREBRAL
AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCOR-
TICAL INFARCTS AND LEUKOENCEPHALOPATHY
(CADASIL)
1C. Sarti, 1F. Pescini, 1V. Palumbo, 1A. Poggesi, 2S. Bianchi, 
2M.T. Dotti, 2A. Federico, 1D. Inzitari, 1L. Pantoni
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Background CADASIL is an inherited (autosomal dominant) vascular
disease clinically characterized by recurrent transient ischemic attacks
and/or strokes, migraine, mood disorders, cognitive impairment, and
seizures. Radiological hallmarks are diffuse white matter abnormalities
and/or lacunar infarcts visible on MRI or CT. Genetic mutations are
located on chromosome 19p13.1 on the Notch3 gene.
Migraine is the symptom of onset of the disease in 40% of cases [1]
and has been described in up to 77% of patients in the advanced phase
of the disease. Migraine with aura has been reported in up to 40% of
cases. About 30% of patients have atypical aura, and atypical plus typ-
ical aura has been described in 27% of cases [2].
Methods We describe the clinical characteristics of 14 consecutive
CADASIL patients (5 males) belonging to 9 unrelated families.
Results The time of the first neurological evaluation was at an
advanced age (mean 51±15 years). Onset of the disease was retrospec-
tively judged to be earlier (mean age 29 years±16) with migraine as the
presentation symptom in 64% of patients. On presentation no patient
had migraine with aura. Migraine was present in 86% of patients in the
advanced phase of the disease. Three patients (21%) had migraine with
aura, 2 of them (14%) had typical and prolonged aura. The other clin-
ical features were TIA/strokes (57%), cognitive deficits (71%), and
mood disturbances (79%).
All patients presented confluent or partly-confluent MRI white matter
changes with the exception of 2 young patients (26 and 28 years) clin-
ically characterized by isolated migraine. Involvement of the temporal
lobes was variable in terms of severity. Family history was positive for
at least one CADASIL clinical hallmark in all cases. Notch3 mutations
involved exon 11 (3 families), 19 (2 families), and exons 3, 4, 6, and
10 in one family each.
Conclusions CADASIL appears to be an underestimated disease.
The phenotypic spectrum is variable ranging from pauci-sympto-
matic cases to severe disease. Migraine is frequently the earliest
symptom of the disease occurring at a relatively young age.
CADASIL should be suspected in patients with migraine who have
MRI white matter alterations of moderate to severe degree and
a positive family history for at least one clinical hallmark of the
disease. 
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PRIMARY CHRONIC HEADACHES IN ITALY: ANALYSIS OF
DIAGNOSES WITH THE AID OF A DEDICATED SOFTWARE
BASED ON ICHD-II CRITERIA
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Background We recently developed a software, the Primary
Headaches Analyser 1.0 INT (PHA), to analyse the clinical data from
patients affected by primary headaches [1]. This programme is based
exclusively on the International Classification of Headache Disorders
2nd edition (ICHD-II) criteria [2]. This software examines all the diag-
noses of primary headaches on the basis of the variables needed to ful-
fil these mandatory criteria.
Methods We tested the diagnoses of chronic primary headaches with
the aid of the software PHA, by entering and analyzing data reported
in the clinical chart and headache diaries from 200 consecutive patients
affected by primary chronic headaches and evaluating the correspond-
ing output diagnoses.
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Results The diagnosis of 1.5.1 Chronic migraine was obtained in 68
cases (34%), and that of probable 1.6.5 Chronic migraine + 8.2.8
Probable medication-overuse headache in 46 (23%). 2.3 Chronic ten-
sion-type headache and 2.4.3 Probable chronic tension-type headache
+ 8.2.8 Probable medication-overuse headache were diagnosed in 24
(12%), and 2 (1%) patients, respectively. Probable medication-overuse
headache (n=46) included combination analgesics (n=12), analgesics
(n=11), triptans (n=9), a combination of acute medications (n=7), opi-
oids (n=4), and ergot derivatives (n=3). In the two patients with a diag-
nosis of 2.4.3 Probable chronic tension-type headache + 8.2.8 Probable
medication-overuse headache, combination analgesics were responsi-
ble for medication overuse. Moreover, 4 and 12 patients, respectively,
received both the diagnosis of 1.5.1 Chronic migraine +2.3 Chronic
tension-type headache and of 1.6.1 Probable migraine without aura
+ 2.3 Chronic tension-type headache. In the remaining 44 cases (22%),
none of the chronic primary headaches defined by ICHD-II were given
as an output diagnosis by our software. This was mainly due to the fact
that insufficient criteria were fulfilled for the diagnoses of 1.1 Migraine
without aura + 1.5.1 Chronic migraine or, more infrequently, 2.3
Chronic tension-type headache.
Output diagnoses included 1.1 Migraine without aura, 1.6.1 Probable
migraine without aura, 2.4.1 Probable infrequent episodic tension-type
headache + 2.4.2 Probable frequent episodic tension-type headache,
and 14.1 Headache not elsewhere classified. None of the patients
whose clinical sheets were examined received a diagnosis of 4.7
Hemicrania continua or 4.8 New daily-persistent headache.
Conclusions Our software (PHA) allowed the diagnoses of chronic
migraine or chronic tension-type headache or their probable forms in the
case of medication overuse in 78% of the patients with more than 15 days
per month examined. In the remaining cases, the inability to provide the
above diagnoses can be explained in about one quarter of cases by the fact
that the mandatory criteria for both diagnoses are too stringent and do not
reflect modifications of the headache patterns in these chronic forms.
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Introduction The present study was conducted in order to compare the
sensitivity of the newly developed World Health Organization
Disability Assessment Schedule II for detecting disability due to chron-
ic pain with two established instruments, one generic (SF-36) [1] and
one specific for headache (HIT-6) in patients affected by chronic daily
headache (CDH) with and without analgesics overuse. WHO-DAS II
consists of 36 items, grouped into 6 domains, 5 being related to per-
sonal activities and 1 to social life events: D1 communication abilities;
D2 mobility impairment; D3 self care; D4 interpersonal relationship;
D5 familial/working daily activities; D6 social life participation rate.
Methods Forty consecutive patients (30 females and 10 males),
affected by CDH with or without analgesic overuse and observed
during a 6-month period were interviewed through SF-36, HIT-6 and
the 36-item version of WHO-DAS II scales, each one in its validated
Italian version. Headache diagnosis was made according to ICHD-II
criteria [2]. No patient had taken prophylactic medications for
headache during the 6 months preceding the observation. Statistical
analysis included partial correlation tests between items of the three
instruments and alfa Cronbach parameter for evaluation of WHO-
DAS II internal consistency.
Results A positive correlation was found between all items of SF-36
and some items of WHO-DAS II, in D4, D5 and D6 domains, with sta-
tistically significant differences (p<0.01). D5 and D6 WHO-DAS II
domains correlated positively with all HIT-6 items (p<0.01), D4
domain correlated with items 3, 4, 5, 6 of HIT-6 (p<0.01), D1 domain
with items 4, 5, 6 (p<0.05) and D2 domain with item 3 only (p<0.05).
Discussion and conclusions The above findings show that WHO-DAS
II is comparable to SF-36 and HIT-6 as a tool for disability measure-
ment. No correlations were found between WHO-DAS II items and
headache clinical features, such as disease duration or duration of anal-
gesic overuse. Some SF-36 items, instead, showed a statistically sig-
nificant correlation with duration of illness, but not with the duration
of analgesic overuse. To identify internal consistency between all items
of WHO-DAS II, we used alfa Cronbach parameter. Its value was
between 0.8 and 0.9 for all domains analysed indicating a high internal
consistency, which supports the use of WHO-DAS II as a sensitive
instrument for detecting disability in headache patients, In particular, it
may prove to be a valuable measurement tool for disability in chronic
headache patients, and it could be useful for indicating effectiveness of
therapy and guiding clinical management in these patients.
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Introduction The International Classification of Headache Disorders
(ICDH-II, 2004) remarkably modified the diagnostic criteria of med-
ication-overuse headache (MOH), and also proposed clinical criteria to
differentiate headache between different overused medications.
Subsequently, these clinical criteria were excluded in the revision of
the International Headache Seminar held in Copenhagen in March
2004, due to lack of reliable data from the literature.
Objective The aim of the present study was to analyse, for the first
time in a systematic way, the clinical characteristics of headache in a
sample of patients suffering from MOH.
Patients and methods We studied 51 patients with chronic daily
headache who took analgesics ≥ once per day for more than three
months, and were treated for detoxification as in-patients. The study
included 46 women (90.2%) and 5 men (9.8%), with a mean age of 53
[SD 12] years. The patients were divided according to the medication
overused. The quality, the site, the severity, and the accompanying phe-
nomena were evaluated, taking into account also the characteristics of
the pre-existing headache and the response to the medication used. The
data were analysed using the Statistical Package for the Social
Sciences (SPSS 12.0).
Results The overused medications were: combination analgesics in 20
patients (39.2%), simple analgesics in 17 patients (33.3%), triptans in
10 patients (19.6%), and ergotamine in 4 patients (7.8%). The more
common pre-existing headache was migraine without aura (39 patients,
76.5%). The pain was more frequently pulsating (28 patients, 54.9%),
bilateral (29 patients, 56.9%), and of severe intensity (34 patients,
66.7%). Accompanying phenomena were present in 43 patients
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(84.3%), the more frequent being nausea associated with phonophobia
and photophobia. The quality, site and intensity of pain, and the type of
accompanying phenomena did not differ significantly among overusers
of different medications (p=NS). The overused medications were
effective in reducing headache and the mean time to the resolution of
pain was 72 [SD=87] minutes.
Conclusions The headache in this sample of patients with MOH was
more frequently pulsating, bilateral, severe and associated with nausea
and phonophobia and photophobia. The clinical characteristics were
not different according to the various types of overused medications,
supporting the revision of the International Headache Seminar of
Copenhagen (2004). The pre-existing headache and the response to
overused medications did not influence the characteristics of MOH.
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In the Western world, 2%–4% of deaths are due to suicide, incidents
and murders. Suicide is experienced as a predictable, and therefore pre-
ventable death; its occurrence causes a sense of anguish in relatives and
frustration and impotence in physicians. Chronic somatic pathologies,
such as diabetes, cardiopathy, cancer, stroke and correlated problems
like pain, weight loss, insomnia etc. increase vulnerability and predis-
pose to the risk of suicide. Our aim in this study was to evaluate the
presence of both humoral disorders and suicide risk in 300 patients
affected by chronic daily headache and medication-overuse headache,
who were observed for 24 months in our Centre.
We based our work relying upon interviews, collection of anamnestic
data related to the premorbid period, information given by patients
concerning the sufferers’ behaviour during the day, attitudes towards
others, maintaining of previous interests, and modifications of the bio-
logical rhythm.
Moreover, psychometric tests were administered, revealing a remark-
able correlation between humoral disorders and headache, impairment
of working activity, relationships and family life.
Through structured interviews with patients and family, the presence of
both depressive symptomatology and suicide ideation before the
appearance of chronic daily headache has been evaluated.
Finally, our purpose was also to establish if, unlike other pathologies,
suicide risk was high or remained just intentional.
Preliminary data indicate 42 patients (21%) with positive results; more
specific tests (SSI, BRFL) were performed in order to quantify the
importance, intensity and pervasiveness of suicide ideation.
CASE REPORTS
DIFFICULTIES IN MIGRALEPSY DIAGNOSIS: A CASE
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Migraine and epilepsy are paroxysmal disorders showing clinical and
epidemiological comorbidity whose possible relationship remains to be
clarified. When a seizure begins during or close to post-aura symp-
toms, we refer to migralepsy. This phenomenon is described in subjects
suffering from migraine with aura; the ICHD-II (2004) diagnostic cri-
teria codify this new entity at 1.5.5 (in the chapter on migraine). A 36-
year-old man was referred to our headache centre with aura symptoms.
The patient’s history (birth, physiological history and psycho-physical
development) was normal. His history of migraine (without aura and
showing a weekend pattern) started at age 20. At 34, he began experi-
encing frequent visual bilateral symptoms lasting 10 minutes and never
followed by headache (12 episodes/month). These occurred, in partic-
ular, in the evening, after work. He described flashing lights, diffuse in
the visual hemifield on the headache side, lasting 5–10 minutes. He
also recalled two episodes of dejà-vu symptoms associated with nau-
sea. At age 36, he reported an episode of his typical visual symptoms
associated with a dejà-vu perception, perception of a “clean” smell (of
fresh laundry), and nausea, lasting about 10 minutes. He then lost con-
sciousness, fell to the ground, and displayed tonic seizure of the limbs
with laceration of the tongue. After about five minutes, he resumed
normal respiration, but remained rather unresponsive and confused
until the arrival of rescue workers. Apparently, this episode was not
followed by headache. MRI and basal EEG were normal, whereas
sleep deprivation EEG showed a diffuse and large theta frequency in
the left cerebral hemisphere. The diagnosis was tonic seizure in
migraine with/without aura. The patient began treatment with topira-
mate (200 mg daily).
This patient was referred to us with recurrent migraine attacks and the
appearance of visual symptoms sometimes followed by headache. We
investigated possible comorbidities of the aura: patent foramen ovale
was excluded by transcranial Doppler; we found heterozygous C677T
mutation in the methylene tetrahydrofolate reductase gene. We pre-
scribed acetylsalicylic acid (100 mg daily).
At follow-up (the most recent was three years after the first visit), he
reported a reduction of aura symptoms (about five episodes/month) not
always followed by headache and no migraine attack without aura. No
other seizure occurred and the most recent EEG was normal. 
Migralepsy is a rare form with very few reported cases. Even in the
cases that have been described, the diagnosis is not clear-cut. The dif-
ficulty of arriving at a precise differential diagnosis of visual distur-
bance (aura vs. occipital partial seizures and elementary hallucinations)
does not support the hypothesis that migralepsy is a primary entity in
its own right.
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Background Cluster headache often leads to mood changes in
patients, in particular, to depressive reactions and sometimes to sui-
cide. However, there are no controlled studies on the comorbidity of
cluster headache and affective disorders such as manic-depressive ill-
ness. We report on a patient who developed his first manic episode
while suffering from a cluster episode.
Case report A 34-year-old male patient has been suffering from
episodic cluster headache according to IHS criteria for 8 years. He
experienced one cluster episode per year with a duration of about 2
months. The left-sided cluster attacks occurred about 4 times a day
with a single duration of about half an hour. Oxygen inhalation, and
subcutaneous sumatriptan promptly aborted an attack. In recent
episodes, verapamil at a dosage of 360 and 480 mg per day was effec-
tive as prophylactic agent. At the beginning of his last cluster episode,
he received steroids from his general practitioner at a daily dosage of
125 mg per week, which was progressively decreased. At first the
attacks stopped, but then recurred after 10 days; thus the patient was
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admitted to our Headache Centre. However, a few days later, while still
under steroids, the patient rapidly developed manic symptoms and had
to be admitted to a psychiatric isolation ward. Treatment with quetiap-
ine 300–600 mg per day was started, and after 10 days the manic symp-
toms disappeared; cluster attacks occurred occasionally under this
monotherapy.
Conclusions To our knowledge, this is the first report on the onset of
manic symptoms during a cluster episode. Since the patient had some
endogenous depressive episodes in the past, the diagnosis of manic-
depressive illness was made according to the International
Classification of Disease, 10th edition (ICD-10). The manic episodes
were probably induced by steroids or by steroid withdrawal. We con-
clude that cluster headache patients with a history of affective diseases
should not be treated with steroids but with quetiapine or lithium,
which are effective in both conditions.
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Hypnic headache (HH) is a primary headache disorder, classified in the
fourth chapter of ICHD-II, which occurs exclusively during sleep and
usually begins after the age of 60 years [1]. The natural evolution of
HH is not well known, but it is assumed that it tends to be chronic
unremitting. A follow-up of at least 2 years is described for only 25
patients among the 85 cases reported in the literature; according to the
outcome data obtained from these patients, we recently proposed to
distinguish between chronic and episodic HH [2].
A 63-year-old woman complained of a dull, severe headache in the
vertex, which developed only during sleep and awakened the
patient, without any accompanying signs or symptoms; the headache
completely resolved 30 minutes after awakening. She referred the
first episode two years before our visit and its recurrence with a very
low rate (one attack every six months, for a total of four episodes,
the last one just before the observation). Due to the short duration of
the attack, the patient did not take any drug. A detailed interview
revealed the presence of two more forms of primary headache
(migraine without aura and infrequent episodic tension-type
headache). General and neurological examinations, laboratory tests,
and brain MRI with gadolinium were normal.
To our knowledge, this is the first case of a headache fulfilling ICHD-
II criteria for HH with an infrequent pattern, and it supports our previ-
ous observations regarding the possibility of an episodic evolution of
this rare primary headache.
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We present the case of a 74-year-old man referred because of the onset
in the previous month of a severe head pain occurring as a series of
stabs (generally 3–5) in the left parietal area, lasting up to two seconds
and recurring with irregular frequency without any accompanying
signs or symptoms. He never experienced a recurrent headache before.
The pain occurred every hour during the morning, and two or three
times in the afternoon. The stabs presented with an average frequency
of four days per week. His medical history revealed the presence of
ischemic heart disease with atrial fibrillation and hypertension.
Because of his heart condition, a cardiac pacemaker was implanted and
he regularly took anticoagulants and hypotensive drugs. The general
and neurological investigations were normal. A brain CT scan with
contrast medium revealed no alteration; it was not possible to perform
a brain MRI because of the presence of the heart pacemaker. We sug-
gested indomethacin at the dose of 50 mg daily. From the second day
of therapy the stabs disappeared. He is still headache-free after 3
months of follow-up.
Primary stabbing headache is classified in ICHD-II within chapter 4
“Other Primary Headaches”. The short-lasting duration and the irregu-
larity of its frequency justify the low rate of consultation, despite the
relative diffusion of the condition, which occurs in 35% of the general
population, according to recent data. In the same population-based
study, the peak was reached in the third decade; the onset in the elder-
ly is rarely reported [1].
The peculiarities of our case are: i) the sudden onset in the elderly; ii)
the prompt response to low indomethacin dose. Further studies are
warranted to better specify the diagnostic criteria for this form of pri-
mary headache and its treatment.
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The cornerstone of migraine diagnosis, in the absence of pathognomon-
ic biological or imaging markers, are the anamnestic data, with particu-
lar regard to the clinical features of the headache, and the general and
neurological examinations. Neuroimaging or laboratory tests are useful
to exclude a secondary origin, when: i. the characteristics of the
headache do not fulfil ICHD-II criteria for the diagnosis of migraine; ii.
the general or neurological examinations are abnormal; iii. the anamnes-
tic data show the presence of alarm features, the so-called red flags. 
A 37-year-old woman presented with a one-month history of daily,
severe, diffuse headache with phonophobia, photophobia, nausea, and
vomiting. She attributed these symptoms to migraine, a condition she
suffered from since her twenties with an average frequency of 2 attacks
per month. She decided to undergo a medical consultation because of
the lack of response to the usual therapy (triptans and NSAIDs) and the
progressive worsening of the symptoms. General and neurological
examinations did not reveal any abnormalities. A brain CT scan
showed the presence of several metastases in both hemispheres with a
dislocation of the mid-line structures. Further investigations demon-
strated a primary ovarian neoplasm. The patient died two months later. 
The possibility of a secondary origin was suggested by the accelerating
pattern of a previous well-known headache and the lack of response to
treatment, both of them to be considered as red flags. The peculiarity
of this case is essentially represented by the normal general and neuro-
logical examinations despite the dramatic neuroimaging picture.
293
Secondary headaches fulfilling ICHD-II criteria for the diagnosis of a
primary headache are described also for other forms (e.g. cluster
headache, TACs) [1–2]. The adherence to major TACs ICHD-II crite-
ria and a normal general and neurological visit are necessary, but not
sufficient to exclude a secondary process. Thus, the appearance of a
“red flag” in a headache patient should always prompt a re-evaluation
to exclude the presence of a secondary cause.
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Serotonin syndrome (SS) is a rare pathological condition related to the
concomitant use of drugs that increase 5-HT availability; the patho-
physiology of SS seems to be ascribed to the stimulation in the brain-
stem of 5-HT1A receptors and the inhibition of 5-HT1A dopaminergic
transmission, secondary to serotonergic hyperactivity. SS includes sev-
eral neurological and autonomic manifestations that follow administra-
tion or an increased dosage of serotonergic drugs, and is clinically
defined in the presence of at least three of the following signs/symp-
toms: mental status changes, myoclonus, hyperreflexia, tremor, fever,
diaphoresis, shivering, and diarrhoea [1]. Because of their actions, trip-
tans have been implicated in the pathogenesis of SS, in particular, if
taken with drugs which increase 5-HT levels. We describe the case of a
61-year-old woman, who presented at a first visit a headache fulfilling
ICHD-II criteria for probable chronic migraine without aura and proba-
ble triptan overuse headache. She treated her attacks with triptans, tak-
ing an average 29–30 doses per month for at least 6 months; sometimes
(once a week) she had to take triptans twice daily. Furthermore, she took
mirtazapine 30 mg/day for a depressive syndrome. She referred episodes
of intense sweating, mental confusion, shiver, tremor, and inconstant
diarrhoea, lasting 3–4 hours and leaving her prostrate. She complained
of such episodes a few hours after taking a second dose of triptan. She
first reported these symptoms five months before our observation, but
she attributed them to her depressive status. Symptoms disappeared after
the withdrawal of mirtazapine and a detoxifying treatment (follow-up 3
months), whereas the headache frequency remained unchanged; there-
fore, the final diagnosis was chronic migraine without aura.
The peculiarities of this case are: i. the temporal pattern and the sponta-
neous remission of each episode, indicating a recurrent and mild form of
SS; ii. the correlation between taking a double dose of triptans and the
onset of SS symptoms, documented by a diary; iii. the concomitant use
of mirtazapine, a drug rarely implicated in generating this syndrome.
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CONTRIBUTION OF NEUROBIOLOGICAL AND PSYCHO-
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Even though it is not yet clear whether the misuse and/or abuse of anal-
gesics or triptans in migraine may be involved in headache chronicity,
chronic pain and pain relief are considered the most important features
in inducing a habitual behaviour as therapeutic need. It is well known
that complex brain areas, as well as different neurotransmitter systems
and complex responses participate in the biology of the reward brain
system. Comorbidity for psychiatric disorders, such as anxiety and
depression, as well as negative life events, exacerbate headache and
quality of life in patients suffering from headache [1]. Stressful peri-
ods, can induce disruption in these interneural interactions and result in
a craving for drugs to relieve the pain and bad feelings. Serotonin plays
an important role in migraine pathogenesis, and drugs such as triptans,
5-HT1B/1D agonists, are the first choice for acute migraine therapy.
Recent findings support the hypothesis that serotonin could contribute
to the development of mechanisms underlying the reward system in the
brain, inducing a compulsive habit for consumption of antimigraine
analgesics [2]. The present paper would like to contribute to clarifying
the above described mechanisms. For this purpose, a case report is
introduced and discussed.
A 45-year-old woman complained of primary migraine for many years.
The headache occurred two, sometimes three times a week. Prodromic
symptoms, such as tension in the orbital region and nausea, preceded
the headache. For about two years, the patient abused of analgesics
(NSAIDs), and during the last year she took triptans (9 to 10 times a
month during the last three months) and analgesics. Despite the drug
treatment, headache recurred more frequently, and the characteristics of
the pain changed, from being sharp and starting abruptly to often pre-
senting in one hemiscalp and spreading subsequently to the entire head.
The clinical story of the patient revealed psychiatric co-morbid disor-
ders for anxiety and depression following a stressful period for job-
related problems (mobbing?). A genetic study was carried out to inves-
tigate inherited predisposition to thrombophilia and verify the possibil-
ity of sinus venous thrombosis. A Factor V gene mutation was found.
Moreover, neuroimaging investigations (MRI and intracranial venous
MR angiography) did not show any pathological brain conditions but
revealed a dominant dilated and tortuous right transverse sinus, where-
as the left transverse sinus was hypoplastic. During hospitalization,
drug treatment was stopped and prophylaptic therapy was started.
In conclusion, this case report suggests that headache chronicity might
be caused by biological as well as psychological traits. Correct man-
agement of migraine and headaches may contribute to modifying habit-
ual behaviour and reducing consumption of drugs in chronic sufferers.
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University “Sacro Cuore”, Rome, Italy; e-mail: edotasciotti@
hotmail.com
Introduction With this case report we want to emphasize how impor-
tant it is, and how much work still needs to be carried out in terms of
patient education and divulgation of information about headaches.
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Case A 41-year-old man suffered from headache (the first episode
occurred about 15 years ago). This affection became worse in frequency,
intensity and refractory to the rescue dose in the last 12 months, com-
promising his job. The characteristics of this headache were: daily fre-
quency; right-sided localization, beginning in the posterior region of the
head; absence of aura except for tension located in the cervico-occipital
area over the paravertebral muscles, associated with pain in the point of
emergency of Arnold’s nerve; bilaterally lasting ≥24 hours. Pain intensi-
ty was measured with Visual Analogue Scale (VAS). Phonophobia and
photophobia were so strong during the crises that they forced the patient
to abandon his activity. Under prescription, the patient had taken 500 mg
effervescent tablet as rescue dose. Consecutively, because the headaches
did not resolve, he took 10 mg of rizatriptan RPD, which he defined has
being unsatisfactory for pain relief. The patient did not receive any infor-
mation about the rescue dose nor prophylactic drugs from the previous
doctors, even though he had been suffering from headache for the past
15 years and was experiencing increased headache frequency.
The patient underwent algological examination: finger pressure caused
pain at the paravertebral cervical muscles conserving flex extension
and laterality of the first trigeminal branch. The trigger point was on
the right trapezoidal muscle.
Chronic sinusitis was found in the patient, who worked in an area sub-
ject to climatic variations. He was allergic to acetylsalicylic acid.
Instrumental diagnosis, x-rays of the head and cervical spine in two
separate moments (23/02/06), showed a reduction of physiological cer-
vical lordosis, which resulted in osteoarthritis. The patient was pre-
scribed the following therapy:
Fluxarten 5 mg at 9 p.m.
Laroxyl 5 mg gtt at 9 p.m.
Sirdalud 1/2 tablet bid
Rizatriptan RPD 10 mg s.l., when needed.
Therapeutic efficacy was and is still being evaluated monthly by VAS.
Results The described therapy was followed continuously considering
the high tolerability of the prophylactic drugs. After 4 weeks, the
monthly frequency of crisis decreased to three, with VAS=7 and the
patient responded to rizatriptan taken at the beginning of the crisis.
After 8 weeks, the frequency decreased to 2 crises, VAS=5, and the
patient responded to rescue dose. Currently, the patient is drug free and
refers two headache crises per month. He has returned to work and now
considers his social life normal.
Conclusions This case represents the paradigm of an incorrect treat-
ment for headache symptoms, regarding both the most suitable strate-
gy to use and when to take the symptomatic drug. It is evident how a
symptomatic strategy for daily headache exposed the patient to drug
overuse and to an unsuccessful therapy causing social and working
problems. It should be mentioned that the lack/absence of correct infor-
mation regarding early prophylaxis also contributed to the unsuccess-
ful resolution of headache pain.
HEMIPLEGIC MIGRAINE WITH PROLONGED SYMPTOMS
IN ATYPICAL STURGE-WEBER SYNDROME
M.A. Tavoni, N. Zamponi, E. Cesaroni, L. Porfiri, C. Cardinali
Riuniti University Hospitals, Paediatric Neurology Department,
Children’s Hospital “G. Salesi”, Ancona, Italy; e-mail: npisalesi@
ao-salesi.marche.it
Introduction The Sturge-Weber Syndrome (SWS) is a rare disease
characterized by an encephalotrigeminal or leptomeningeal
angiomatosis and facial vascular nevus (port-wine stain). It is part of a
phenotypic spectrum, which includes other syndromes with capillary
angiomatosis malformations in various sites, such as Klippel
Trenaunay Weber Syndrome with malformations not only of the capil-
laries, veins, arteries, and lymphatic vessels, but also of soft tissues and
bone hypertrophy [1].
Case report We report a patient with a mixed phenotype, of a facial
nevus on the right forehead, right arm and left leg soft tissues and
bone hypertrophy, obesity, high blood pressure, and epileptic seizures,
who presented at 14-years of age with pulsating unilateral headache
with visual disorders and acute - prolonged left hemiparesis. None of
the episodes were preceded or accompanied by loss of consciousness
or ictal clonic jerks. The EEG was normal during the headache
episode, MRI showed the typical Sturge-Weber angiomatosis without
ischemic lesions.
Results and discussion Our case report suggests a Sturge-Weber atyp-
ical syndrome that could be responsible for symptomatic migraine-like
headache. According to criteria of the ICHD-II classification 2004, this
syndrome could be clinically diagnosed with probable migraine with
aura (subtype 1.6.2) with atypical features.
Vasomotor modifications in venous flow in relation with pial angiomato-
sis are probably at the origin of these migraine-like episodes. Chronic
oligoemia and the pre-existent metabolic cortex damage caused by
hypoperfusion would worsen the clinical symptomatology [2].
Epileptic seizures between the prodromic and pain phase of migraine
attack are rarely reported in paediatric age and in patients affected by
SWS. Probably, the migraine attacks, like the seizures, are to be con-
sidered another expression of brain damage as a result of microvascu-
lar disturbances.
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A CASE OF POSTERIOR SCLERITIS: HEADACHE ATTRIB-
UTED TO OCULAR INFLAMMATORY DISORDER
1S. Ruffatti, 1L. Santelli, 1F. Maggioni, 1E. Mampreso, 2F. Dainese, 
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Introduction A case of posterior scleritis is described. Posterior scleritis
is an uncommon form of scleral inflammation, which can be confused
with several inflammatory and non-inflammatory ocular diseases or ocu-
lar tumors. Anterior scleritis can be associated with this condition. It may
be idiopathic or associated with systemic disease, particularly connective
tissue disorders [1]. In the International Headache Society Classification
[2] it is included in the chapter “Headache attributed to ocular inflamma-
tory disorder” (11.3.4). Periocular pain, pain on movement and decreased
vision are the most frequent symptoms [1]. Pain can also be referred to
the forehead, maxilla, or sinuses and is described as penetrating in char-
acter. Redness of the affected eye can be observed. Ultrasonography is the
key investigation necessary to make the diagnosis of posterior scleritis
[1]. CT scan and fundus fluorescein angiography can also be used.
Case history We report a case of a 26-year-old woman who began to
complain of right-sided ocular and periocular pain, exacerbated by
ocular movements, irradiating to the ipsilateral temple and zygoma, not
associated with visual disturbances. Admitted to our Emergency
Department, she underwent an ophthalmological consultation, which
showed a normal fundus oculi and visual acuity. Trigeminal neuralgia
was suspected and she was then treated unsuccessfully with analgesics.
Seven days later, she underwent a second ophthalmological and a neu-
rological consultation, which were both normal. After one week, she
experienced a worsening of facial pain associated with conjunctival
injection, eyelid edema, and developed a central scotoma. She was then
admitted to our clinic. Fundus oculi showed in the right eye a hyper-
emic optic disc with blurred margins. Blurred vision in the right eye
with a central scotoma was referred. The remaining neurological exam-
ination was normal. A third ophthalmological consultation showed a
visual acuity of 1/10 in the right eye (10/10 in the left) with conjuncti-
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val injection. Fundus oculi confirmed the above reported findings and
some retinal folds; ultrasonography revealed scleral thickening and
exudative retinal detachment, suggesting a posterior scleritis. Chest X-
ray, routine blood tests, brain MRI with gadolinium and cerebrospinal
fluid examination were normal.
The patient was treated with methylprednisolone i.v. 1 gr/day for 10
days with complete regression of pain and clear improvement of visu-
al disturbances. Ultrasonography performed 10 days after the end of
treatment showed a reduction of scleral thickening, fluid in the Tenon
capsule, and regression of retinal detachment. Visual acuity was 6/10
in the right eye. A month after discharge the patient began to complain
of left periocular pain, without visual loss. Ultrasonography showed
posterior scleritis in the left eye; she fully recovered after a further
course of steroid treatment.
Discussion Posterior scleritis is a common form of scleritis and
should be suspected in patients who present with ocular pain and
visual loss. It is one of the most commonly misdiagnosed condi-
tions in ophthalmology, especially when, as in our case, pain is not
associated with visual disturbances or ocular signs at the onset of
symptoms.
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HEADACHE AND ISOLATED PARALYSIS OF THE 12TH
CRANIAL NERVE AS A PRESENTING SYMPTOM OF DIS-
SECTION OF THE INTRAPETROSAL TRACT OF THE INTER-
NAL CAROTID ARTERY
S. Tenaglia, A. Baldi, P. Sarchielli, P. Calabresi
Headache Centre, Neurologic Clinic, Department of Medical Surgical
Specialties and Public Health, University of Perugia, Perugia, Italy; 
e-mail: baldianto@libero.it
Case description A 60-year-old man came to our attention for the
onset of symptomatology characterized by continuous, left-sided, fron-
to-orbital headache of moderate intensity, associated with photophobia,
which did not regress after taking common analgesics. After about
three days, the patient presented with a worsening of the headache,
which was of stronger intensity and with the appearance of dysphagia
and dysarthria.
The neurological examination revealed a deficit of the left XIIth cra-
nial nerve. Brain CT, brain MRI, Echo-colordoppler of the supra-aor-
tic vessels, and ultrasound of the neck were normal. Angio-CT and sub-
sequent angio-MRI of the vessels of the neck showed findings com-
patible with dissection of the intrapetrosal segment of the left internal
carotid artery.
Discussion Carotid artery dissection is an important cause of stroke
in the young. Headache and facial pain, often associated with
Horner’s syndrome, constitute a common onset symptom and may
precede stroke by a few days [1]. Headache associated with deficit of
the hypoglossal nerve is not a common onset symptom, and only a
few cases are described in the literature [2]. More frequently, this
symptomatology may be secondary to diseases of the jugular fora-
men, and in this case, is associated with paralysis of other cranial
nerves (IXth and Xth).
In the case described, brain MRI excluded intracranial diseases. Echo-
colorDoppler of the supra-aortic vessels could not visualise the dissec-
tion, in that this involved the intraosseous segment of the internal
carotid artery, thus warranting a specific study of the complete intracra-
nial course of this artery.
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PAINFUL RECURRENT BILATERAL OPHTHALMOPLEGIA
SECONDARY TO BILATERAL CAROTID CAVERNOUS
FISTULA
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Case description A 68-year-old woman presented to us one week
after onset of symptoms characterized by a stabbing headache of
strong intensity, in the retro-orbital and left fronto-temporal regions,
with nausea, photophobia and phonophobia associated with diplop-
ia. The neurological examination revealed paresis of the left VIth
cranial nerve, tactile hypoesthesia, and left-sided pain of the first
division of the trigeminal nerve.
Brain CT revealed slight enhancement with gadolinium in the left
cavernous sinus. Blood tests, Echo-colorDoppler ultrasound of the
supra-aortic vessels and the superficial temporal arteries were normal.
The patient was treated with prednisone 50 mg/day for one week and
subsequently 25 mg/day. After 48 hours the headache regressed, but
the diplopia persisted.
After two months, the patient also presented diplopia on right gaze,
eyelid edema, conjunctival injection in the right eye, associated with
unilateral retro-orbital pain. The neurological examination revealed:
proptosis, eyelid edema, conjunctival chemosis, partial deficit of the
right IIIrd cranial nerve, and deficit of the left VIth cranial nerve.
Brain MRI was repeated and in the norm. Subsequently, brain angio-
MRI was performed, which revealed a bilateral dural fistula of the
cavernous sinuses and the occiptal foramen. 
The lesion was treated with embolization via the left transjugular
approach.
Discussion Dural arteriovenous fistulas (AVFs) are a rare condition,
with a rate of incidence of 0.16 per 100 000 inhabitants/year; with respect
to other intracranial vascular malformations they can be acquired,
often as a consequence of cerebral venous thrombosis, previous head
traumas, aneurysmal rupture, and local and systemic infections [1].
Cavernous carotid fistulas constitute 20%–40% of all dural AVFs
[2], and are formed by an abnormal communication between the
carotid artery and cavernous sinus.
Venous hypertension subsequent to shunt formation results in retro-
grade venous drainage into the ophthalmic venous system, which is
responsible for the ocular symptoms, cortical venous reflux, and ten-
dency to haemorrhage.
Headache is rarely a presenting symptom, but when present, it is
associated with ophthalmoplegia. The differential diagnosis is with
other forms of painful ophthalmoplegia.
Neuroimaging studies are normal or furnish indirect signs (often
non-specific) of fistula presence; the only certain diagnostic investi-
gation is brain angio-MRI [1].
In the case of carotid-cavernous fistulas, among the various thera-
peutic options endovascular embolization is the least invasive
method, and when possibile, the transvenous access can lead to com-
plete obliteration of the fistula [1].
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PAINFUL OPHTHALMOPLEGIA WITH CSF ALTERATIONS: A
CASE REPORT
A. Mercurio, G. Caranci, M. Altieri, V. Di Piero
Headache Centre, Department of Neurological Sciences, University of
Rome “La Sapienza”, Rome, Italy; e-mail: vittorio.dipiero@uniroma1.it
Introduction Painful ophthalmoplegia (PO) is a syndrome character-
ized by the occurrence of periorbital pain and ophthalmoparesis, with
or without the involvement of other cranial nerves, caused by several
different etiologies.
Case historty A 46-year-old man was admitted to our ward, with a
severe dull and steady pain in the right orbit and in the surrounding
area of the forehead, associated a few days later with the appearance of
diplopia and right eyelid ptosis. The neurological examinations showed
a paresis of both the right third and fourth cranial nerves. Physical and
laboratory examinations, trigeminal reflexes, cerebral MRI, arterial
and venous MR angiography were all normal.
A CSF sample showed an elevated protein content (93 mg/dL), with a
positive Pandy reaction and alteration of blood-brain barrier indices,
and was negative for the presence of common infectious agents. Two
days after the clinical admission, the headache disappeared, and the
third and fourth nerve palsy improved significantly, with full recovery
from diplopia a few days later. The increase in CSF proteins persisted
at 2 weeks (73 mg/dL) and 1 month (64 mg/dL).
There are several causes of PO: vascular, inflammatory, infections,
dismetabolisms, neoplasia, trauma, recurrent demyelinating neu-
ropathy and ophthalmoplegic migraine (OM). OM may be suspect-
ed when a severe headache is associated with ophthalmoparesis, nor-
mal MRI investigations and a benign course [1]. In our case this
diagnosis could be hypothesized. In this regard, it is noteworthy that
the IHS criteria (1988) required a single episode (probably because
of its rarity), while ICHD-II criteria require its recurrence [1]. In our
patient, the CSF abnormalities, the single episode and the “non-
migrainous” features of the headache, except for the severity, are
consistent with an uncommon viral infection. Because OM is more
a syndrome than a specific disease, this case suggests that if a diag-
nosis of OM is suspected, the possibility of a benign inflammatory
disease should be considered, in particular, when ICHD-II criteria
are not fully satisfied [1].
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HEADACHE IN A PATIENT WITH CEREBRAL SINUS
THROMBOSIS AND SPONTANEOUS INTRACRANIAL
HYPOTENSION
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1G. Zanchin
1Headache Centre, Department of Neurosciences, University of Padua,
Padua, Italy; 2Headache Centre, Neurological Unit, SS Giovanni and
Paolo Hospital, Venice, Italy; e-mail: edoardo.mampreso@unipd.it
Cerebral venous sinus thrombosis (CVST) is an uncommon, life-
threatening condition that mostly affects middle-aged women. The
principal, and also earliest symptom is headache (80%–90%), followed
by other neurological symptoms. The headache has no specific charac-
teristics, is most often diffuse, progressive, severe and associated with
other signs of intracranial hypertension. It can also be unilateral and
sudden, and sometimes mimick migraine, primary thunderclap
headache, cerebrospinal fluid (CSF) hypotension or subarachnoid
haemorrhage (ICHD-II, 2004). CVST recognizes a wide variety of risk
factors and causes. In 20%–35% of cases, where aetiology remains
unknown, CVST is classified as idiopathic.
Intracranial hypotension (ICH) syndrome is a very infrequent clinical
condition. Its most common symptoms are orthostatic headache asso-
ciated with nausea and/or vomiting, diplopia, hearing disturbances
(hypoacusia, tinnitus), neck pain, visual deficit and vertigo.
We report the case of a 43-year-old female who presented with
headache, which began three days before, characterised initially by
pressing/tightening, and later on, pulsating quality localised at the ver-
tex, of mild intensity, without accompanying symptoms, associated with
mild nausea and tinnitus and occurring only on standing. Brain CT scan
showed less evident cortical sulci, small basal cisterns, small ventricular
cavities, without parenchymal alterations. Neurological examination
showed brisk reflexes and bilateral Babinski sign; fundus oculi was nor-
mal. Brain MRI with contrast and angio-MRI showed thrombosis of the
transverse and sigmoid sinuses and of the internal jugular vein on the left
side, along with alterations suggestive of ICH (pachymeningeal contrast
enhancement and Arnold-Chiari-like descent of cerebellar tonsils). The
clinical history was unremarkable, in particular for thromboembolic risk
factors. Complete blood count, thrombophilia tests, and neoplastic
markers were normal, as were ECG, chest X-rays, somatosensory
evoked potentials, and epiaortic vessels and transcranial EchoDoppler.
Spinal MRI with contrast showed signs of CSF leak (deliquoration) in
the dorsal spine. Then, the clinical history was specifically reassessed
and no possible causes of CSF leak were identified. The patient was
treated with anticoagulant therapy: an angio-MRI performed 18 days
later showed a partial recanalization. At discharge and at two months
follow-up the patient was asymptomatic.
Cases of CVST in patients with ICH secondary to CSF leak are found in
the literature, but only 4 cases of CVST have been associated with spon-
taneous ICH. Based on these observations, and on our case, it could be
possible that compensatory venous sinus dilation and consequent hemat-
ic stasis conditions associated with ICH may predispose to CVST.
MIGRAINE WITH VISUAL AURA ASSOCIATED WITH ARTE-
RIOVENOUS MALFORMATION
1G. Alberti, 2A. Giorgetti, 1G.M. Patruno, 1A. Romorini
1Neurology Service, Magenta Hospital, Milan, Italy; 2Neurology Unit,
Neurology Department, Legnano Hospital, Legnano, Milan, Italy; 
e-mail: alessandro.romorini@ao-legnano.it
Objective To describe two cases of migraine with aura associated with
cerebral arteriovenous malformation (AVM).
Case 1: A 57-year-old woman complained of headache of unusual
severity. She had a history of migraine since age 17, characterized by
an aura of scintillating scotoma for 20–30 minutes on the right side.
Thereafter, a strictly unilateral (left-sided in all cases) throbbing
headache with nausea, vomiting and photophobia occurred. Pain was
mild and responsive to simple analgesics. MRI showed an arteriove-
nous malformation in the left occipital lobe.
Case 2: A 22-year-old woman had a history of migraine since age 15
with visual aura of scotoma and fortification (zig-zag patterns) on the
left side, occasionally accompanied by numbness in the left hand and
face. Her mother had a history of migraine. Three times she had tongue
biting; EEG showed epileptiform discharges. She started valproate
therapy and the visual aura terminated. The aura always occurred on
the left suggesting a possible right-sided structural lesion. MRI showed
a right parietal AVM.
Discussion Arteriovenous malformation is a congenital anomaly that
consists of abnormal arteries and veins without the presence of a cap-
illary bed. The majority of patients initially show intracranial haemor-
rhage, while others may present symptoms of seizures, headaches and
progressive neurological deficits. In the general population, AVMs are
an extremely infrequent cause of headache. Headache occurs in
10%–50% of patients with AVM. The headache may be typical of
migraine. Migraine headaches have a complex pathophysiology, and
(both vascular and neuronal mechanisms) have been proposed. One
possible scenario begins with brain initiated events evolving to cortical
spreading depression (CSD). Susceptibility to CSD appears to be
genetically determined. Structural lesions may cause the initial event.
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When a patient with migraine manifests symptoms always on the same
side, neuroimaging workup is warranted. This should aid in the early
diagnosis of cerebral AVM in order to start treatment before the occur-
rence of cerebral haemorrhage.
TRIGEMINAL NEURALGIA AS PRESENTING SYMPTOM OF
ARNOLD CHIARI TYPE 1 MALFORMATION: A CASE
REPORT
G. Caranci, A. Mercurio, M. Altieri, V. Di Piero
Headache Centre, Department of Neurological Sciences, University of
Rome “La Sapienza”, Rome, Italy; e-mail: vittorio.dipiero@uniroma1.it
Introduction Clinical presentation of Arnold Chiari type 1 malforma-
tion is highly variable. About 13% of patients are asymptomatic;
headache may be the sole clinical manifestation of the malformation;
however, it is one of the most frequent. No headache type seems to be
particular to the malformation; both short- and long-lasting headaches
are described [1].
Case history A 36-year-old woman presented with throbbing-stabbing
pain in the left supraorbital region, which started 3 years earlier. Pain
occurred three or four times a day; the paroxystic pain was severe, and
lasted 7–10 seconds. There were no warning symptoms; trigger factors
were coughing, sneezing, defecation, and nodding movement. There
were no accompanying symptoms but mild nausea. Between attacks,
she was completely pain-free. She was treated with NSAIDs and car-
bamazepine without any improvement. Neurological examination and
laboratory blood tests were normal. MRI showed an Arnold Chiari type
1 malformation with downward herniation of the cerebellar tonsils
through the foramen magnum into the upper cervical spinal canal. A
CT scan of the maxillary and frontal sinuses was normal.
Neurosurgical intervention was suggested.
Discussion Our patient satisfied all the criteria for a symptomatic neu-
ralgia probably caused by the Arnold Chiari type 1 malformation. In
this view, we excluded other types of headaches, such as rhinosinusi-
tis, short-lasting unilateral neuralgiform headache attacks with con-
junctival injection and tearing (SUNCT), supraorbital neuralgia and
idiopathic trigeminal neuralgia. The otolaryngologic examination and
CT scan excluded the possibility of rhinosinusitis.
Due to the location, duration and frequency of the pain described, it
could be compatible with a SUNCT, however, the neurovegetative dis-
turbances, such as conjunctival injection and lacrimation, were absent.
Regarding the supraorbital neuralgia, it lacked tenderness over the
nerve in the supraorbital notch, and there was no pain in the medial
aspect of the forehead in the area supplied by the supraorbital nerve.
Unlike trigeminal neuralgia, there were no trigger points, a very rare
location only in the first branch, and the lack of any response to high
carbamazepine dosage [1].
Conclusions To our knowledge, this is the first case with Arnold Chiari
Type 1 malformation and symptomatic trigeminal neuralgia exclusive-
ly in the first branch. It is probable that the pain is caused by an
anatomical compression on the trigeminal nucleus, and that the differ-
ence in pressure found in the intracranial and intraspinal compart-
ments, evoked by the Valsalva maneuvre, emphasises this compres-
sion, setting off the short-lasting sharp pains [2].
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HEADACHE ATTRIBUTED TO BRAIN ABSCESS: A CASE
REPORT
1A. Giorgetti, 2M. Conti
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Brain abscess is a focal suppurative process in the brain parenchyma
that still contributes to high mortality rates. Outcome is closely related
to correct and early management. In order to evaluate early manage-
ment, we have reviewed the brain abscesses treated in our Department
of Neurosurgery during the last five years, choosing to describe one
case among these. We present a 38-year-old male who was admitted to
the Emergency Department (ED) complaining of a frontal headache
and fever (37.5C°), unresponsive to treatment with NSAIDs. The
patient described weakness and numbness of the right limb, which
resolved in 20–30 minutes. After CT scan resulted normal, the patient
was discharged. The day after, the patient returned to the ED com-
plaining of two new episodes, characterized by weakness and numb-
ness involving the right limb with spontaneous resolution in ten min-
utes, while an intense, diffuse bilateral headache persisted. The patient
was admitted to our department. The neurological examination was
unremarkable. However, within five days the patient showed right
hemiparesis; the inflammatory index was elevated and MRI revealed a
productive, expanding lesion with marked edema in the left parietal
region. The modality of treatment was surgical excision with catheter
drainage-aspiration of the left parietal abscess. Outcome was excellent:
the patient recovered promptly from the hemiparesis, and there was
progressive attenuation of headache until it disappeared. Brain
abscesses are severe infections with lethal outcome in the case of delay
in diagnosis and treatment. Predisposing factors are sepsis of adjacent
organs and bacteraemia. The most frequent clinical manifestations are
fever and headache. Headache is usually the most frequently encoun-
tered symptom. When under observation our patient continuously com-
plained of bilateral, constant headache with increasing intensity to
severe grade, aggravated by straining and accompanied by nausea. A
new type of headache associated with general feeling of illness and/or
fever should direct attention toward an intracranial infection.
IS THE TREATMENT OF HEADACHE BY SPONTANEOUS
CERVICAL CSF LEAK WITH LUMBAR EPIDURAL BLOOD
PATCH A RATIONAL CHOICE?
1E. Ferrante, 2I. Arpino, 1A. Citterio, 2A. Savino
1Neurosciences and 2Emergency Departments, Niguarda Cà Granda
Hospital, Milan, Italy; e-mail: enricoferrante@libero.it
Background Spontaneous intracranial hypotension (SIH) generally
results from spinal spontaneous CSF leakage [1]. Treatment is usually
conservative. Sometimes an autologous EBP at the site of CSF leakage
may be necessary [2].
Objective To evaluate the spread of blood injected into the epidural
space during lumbar epidural blood patch (LEBP) for treatment of
spontaneous cervical CSF leakage (SCCSFL) by MRI.
Materials and methods We report one case of SCCSFL [among the 32
with this condition evaluated between 1992 and the present].
Results A 45-year-old man presented sudden, intense, gravative fron-
to-occipital orthostatic headache. Neurological examination, routine
blood tests, and brain CT scan were normal. Brain MRI showed diffuse
pachymeningeal enhancement. Gadolinium spinal MRI showed CSF
epidural collection from C2 to D3. After one month of bed rest, ortho-
static headache was still present. The patient was treated with autolo-
gous lumbar EBP (25 mL) at the L2-L3 level. The blood was mixed
with 0.05 mL of gadolinium. During and after injection, he remained
in the Trendelenburg position (TP) approximately 30° for 1 hour.
Spinal post-patch MRI showed gadolinium mixed with blood in the
epidural space from the lumbar to cervical level (C2-C3). He subse-
quently remained in the TP for 22 hours. He was asymptomatic within
24 hours after LEBP. At 6-month follow-up he was asymptomatic.
Discussion and conclusions We demonstrate that EBP, even though
injected at the level of the lumbar spine (i.e., far from the site of CSF
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leak), may move upward reaching the cervical segments. This is possi-
bly favoured by the TP. A rapid coagulation response at the level of the
dural hole stops CSF leakage. Thus, EBP at the level of the cervical
spine, where the procedure is difficult to attempt, may not be neces-
sary. To our knowledge, this is the first report that shows the spread of
blood from lumbar to cervical epidural space with LEBP and demon-
strates that the treatment of spontaneous cervical CSF leak with autol-
ogous lumbar epidural blood patch is a rational choice.
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REFERRED FACIAL PAIN AS A SYMPTOM OF NON-
METASTATIC LUNG CANCER: A CASE REPORT AND
REVIEW OF THE LITERATURE
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Introduction Facial pain is a common clinical symptom caused by a
wide variety of underlying conditions, including neurological, odonto-
logical, and otolaryngological pathologies. A patient who developed an
intractable facial pain as an unusual first manifestation of a remote
lung carcinoma is described.
Case Report A 39-year-old woman presented with a 2-month history
of pain localized in the left jaw, with extension into the ipsilateral orbit
and temple. The pain was continuous, moderate to severe in intensity,
and possibly associated with tearing, eye redness, and mild nausea. She
had been smoking 1 pack of cigarettes a day, for at least 20 years. An
odontological visit, a brain MRI and a carotid Doppler ultrasound were
normal. The pain was unresponsive to a number of analgesics as well
as carbamazepine, gabapentin, and prednisone. About 2 weeks before
presentation the patient developed cough and poor appetite. The neu-
rological examination was unremarkable. The physical examination
revealed diminished breath sounds in the left-upper lobe and right
supraclavicular lymphadenopathy. A CT scan of the chest showed a
large solid mass in the superior aspect of the left mediastinum sur-
rounding the supra-aortic vessels and hilus. A fine-needle biopsy of the
supraclavicular node confirmed the presence of a large cell carcinoma.
The ESR was markedly elevated at 83 mm/h. A few days later, the
patient became dysphonic, with laryngoscopic evidence of paresis in
adduction of the left vocal cord. The facial pain gradually improved
and then spontaneously ceased before starting chemotherapy. The
patient was still pain-free after a 6 months follow-up.
Discussion Referred facial pain is a rare symptom of nonmetastatic
malignant lung lesions, and was first described by Des Prez and
Freemon in 1983. Since then, 36 patients (17 M, 19 F) have been
described, including the present patient. The presumed mechanism by
which a thoracic mass can provoke a pain referred to the face is com-
pression of the vagus nerve, which drives pain signals originating from
thoracic and abdominal viscera. Convergence of the visceral and somat-
ic afferents at the level of the descending nucleus of the trigeminal sys-
tem may explain the ipsilateral referred facial pain. The most frequent
locations are the ear (about 90% of cases), jaw and temple. The diagno-
sis can be delayed from 1 month to 4 years after the onset of the pain.
All patients described were smokers. ESR is increased in most patients.
Unlike the previous cases, in the present case the pain spontaneously
disappeared after the patient became dysphonic, indicating the putative
importance of the integrity, at least in part, of the laryngeal nerve.
Conclusions Lung cancer should be included in the differential diag-
nosis of facial pain with atypical signs and/or refractory to treatment.
A CASE OF ATYPICAL INTRACTABLE FACIAL PAIN SEC-
ONDARY TO METASTATIC LUNG CANCER
1S. Ruffatti, 1F. Maggioni, 2F. Mainardi, 2F. Dainese, 3C. Lisotto, 
1G. Zanchin
1Headache Centre, Department of Neuroscience, University of
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Introduction Persistent idiopathic facial pain is defined by the
International Headache Society Classification (ICHD-II) (chapter
13.18.4) as a pain in the face, present daily and persisting for all or
most of the day, confined at onset to a limited area on one side of the
face, deep and poorly localised. According to the classification, pain
around the ear or temple may precede the detection of an ipsilateral
lung carcinoma [1]. Nearly 30 cases of intractable facial pain sec-
ondary to lung neoplasm are described in the literature [2]. We report
a case of intractable facial pain associated with metastatic lung cancer.
Case history A 70-year-old woman presented to the clinic with a 15-
month history of constant, right-sided facial pain, with paroxysms of the
upper teeth, irradiating to the auricular and temporal areas. Six months
after the onset of pain she underwent CT scan and EEG, which were
both normal. She was unsuccessfully treated with amitriptyline (40 mg
per day) and gabapentin (up to 2000 mg per day). She had additional
complaints of poor appetite with weight loss of 4 kg in the last 6 months
and a 9-month history of persistent cough with recent onset of chest
pain on the right side. Auscultation of the lungs revealed abnormal
breath sounds on the right hemithorax; neurological examination
revealed a sensory loss on the right side of the face. Routine blood tests
were normal. Chest X-ray revealed a mass in the right hylar region, con-
firmed by chest CT. She underwent bronchoscopy with lung biopsy; the
histological examination revealed pulmonary adenocarcinoma. Brain
MRI with gadolinium revealed small multiple supratentorial and
infratentorial brain lesions, none of them localized near the right trigem-
inal nucleus and pathways. The patient was treated with chemotherapy
with slight improvement of facial pain. She died shortly thereafter. 
Discussion Facial pain secondary to lung cancer is usually described as
a unilateral constant ache, ipsilateral to the lung mass, frequently
involving the auricular area, and often associated with signs suggesting
a lung cancer (weight loss, digital clubbing, cough, etc.). The pain
seems to be due to invasion of the vagus nerve [2]. Our case referred
to a metastatic lung cancer, but none of the lesions seen on brain MRI
could possibly explain the pain referred by the patient and probably
occurred at a distance from the onset of pain. It is important to consid-
er lung neoplasm as a possible cause of facial pain, especially if it pre-
sents with the characteristics seen above and in smokers.
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Introduction In recent years the quality of medical research in the
field of headaches has reached levels of excellence that have amazing-
ly broadened our panorama of knowledge and justified the develop-
ment in the international publishing field of specialized journals.
Discussion Confinia Cephalalgica was born at the Neurological Institute
C. Mondino in Pavia, at the end of the 1980s. At the beginning, it was the
official journal of the Italian Society for the Study of Headaches, and then
it became the official journal of the University Centres for Adaptive
Disorders and Headache. The journal is published 3 times a year and con-
tains original articles, clinical cases of interest, impossible cases, reviews,
editorials, therapeutic and historical notes, book reviews and congress
reports. The goal of the journal is to constitute a forum for integrating dif-
ferent ideas and expertise through an open dialogue among experts from
different disciplines in order to contribute to the advancement and devel-
opment of knowledge in the field of headaches. The editorial board has
always supported the role of the journal as a tool for communication and
cultural exchange on headache themes, among Italian-English communi-
ties in the world and between Italy and others countries with neolatin lan-
guage and culture. Not less important is its role as the expression of the
patient associations (AL.CE. Group – CIRNA Foundation) that financially
supported the journal. During the last ten years (1997–2006), the journal
published upon invitation or by direct submission more than 120 papers,
furnished by 354 authors. The journal publishes integrated scientific infor-
mation, promoting a multidisciplinary environment that involves first of all
neurologists, but also philosophers and psychiatrists, physiologists and
men of literature. After the restyling of the journal cover in 2004, beginning
this year, Confinia Cephalalgica is editing, except for special events, only
in an online version (free download at the website www.cefalea.it).
Conclusions Although the paper version will be missed, the new elec-
tronic online version is looked at as a challenge, with the desire to be
of valuable assistance for physicians and researchers. Thus, the future
challenge will be the confrontation and exchange of headache infor-
mation on the Web.
HEADACHES: THERAPEUTIC ASPECTS
TOPIRAMATE IN MIGRAINE PROPHYLAXIS: AN OPEN
STUDY
R. Iannacchero, F. Peltrone, U. Cannistrà, E. De Caro
Regional Headache Centre, “Pugliese-Ciaccio” Hospital, Catanzaro,
Italy; e-mail: rosarioiann@tiscali.it
Introduction Patients who suffer frequent severe migraine or chronic
daily headaches are often prescribed prophylactic drugs. A number of
beta-blockers, calcium-channel blockers, serotonin agonists, and anti-
depressants have been tested as prophylactic agents. Topiramate is a
new antiepileptic agent that has GABA agonist properties and has few
side effects when used in low doses.
Objective and methods The aim of this study was to examine the
effects of topiramate on the frequency and intensity of migraine attacks
during prolonged use. Patients who demonstrated 3 to 10 migraine
attacks per month; in addition to migraine, also had chronic daily
headaches from a variety of causes, and all patients had failed treat-
ment with a number of prophylactic agents.
Results We present 35 patients, who kept a daily diary that recorded
the frequency, severity of headaches, and the amount and type of res-
cue medication used. Over a 3–9 months follow-up, 11 patients (30%)
had a very significant improvement in headache frequency (headaches
decreased by over 60%), and 11 patients had a moderate improvement
in headaches (decrease of 40%–60%). Three patients discontinued
therapy due to side effects (lightheadedness, tinnitus, and numbness in
hand) and eight patients did not report any improvement despite hav-
ing been on therapy for over 12 weeks. The remainder of patients had
only 8 weeks of therapy.
Conclusions Our open uncontrolled study in patients with resistant
headaches suggests that topiramate may be a useful prophylactic med-
ication with limited side effects. A large placebo-controlled study is
needed, however, before the results are generalized.
PROPHYLAXIS OF HEMICRANIA CONTINUA WITH TOPI-
RAMATE: REPORT OF 2 CASES
1A. Palermo, 1G. Giglia, 2A. Sandullo, 1G. Cosentino, 1F. Brighina, 
1B. Fierro
1Department of Neurology, Ophthalmology, Otorhinolaryngology and
Psychiatry, University of Palermo, Palermo, Italy; 2General Medicine
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Introduction Hemicrania Continua (HC) is an uncommon and under-
recognized primary headache disorder. It is characterized by a strictly
unilateral continuous headache of moderate intensity with possible
exacerbations, and it is associated with ipsilateral autonomic features,
such as ptosis, miosis, conjunctival injection, lacrimation or rhinor-
rhoea, that tend to be less pronounced than those seen with cluster
headache [1]. The pathophysiology of HC is poorly understood.
HC has generally a prompt and enduring response to indomethacin
25–300 mg daily, although 25%–50% of treated patients develop gas-
trointestinal side effects and unresponsive forms have been described.
Patients who cannot tolerate indomethacin pose a difficult manage-
ment challenge as no other drug is consistently effective in HC.
Recently, Matharu et al. [2] reported 2 patients affected by atypical
forms of HC that showed good response to topiramate.
Case reports Here we describe two patients who fulfil both the IHS
diagnostic criteria for HC. The physical and neurological examinations
and brain magnetic resonance imaging with gadolinium were normal in
both patients.
The patients demonstrated a very good response to indomethacin but
both developed the most common side effect, gastritis, that led us to
stop this treatment. Thus, these patients were started on topiramate
with slow titration to 100 mg b.d, and they had a complete benefit with
the prophylatic treatment with topiramate after 30 days. The dose of
topiramate required to give complete relief of pain was somewhat less
than that usually needed for the antiepileptic effect of the drug. There
were no side effects during the treatment with topiramate.
Discussion and conclusions Topiramate has multiple mechanisms of
action, which include: blockade of the voltage-mediated sodium chan-
nels, enhancement of GABA-mediated chloride influx to GABA antag-
onism of the glutamate kainate/AMPA receptor and carbonic anhy-
drase inhibition. The mechanism(s) of action responsible for the bene-
ficial effect in various headache syndromes is currently unknown.
Whatever the mechanism, if the favourable response observed in our
patients can be confirmed in other cases, it would broaden the thera-
peutic armamentarium available for the treatment of this severe and
sometimes incapacitating condition.
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EFFICACY AND TOLERABILITY OF LEVETIRACETAM IN
EPISODIC AND CHRONIC MIGRAINE
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Background Because of its effect in stabilizing neuronal hyperex-
citability, the antiepileptic drug levetiracetam is a promising molecule
for the prophylaxis of migraine.
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Methods Twenty-five patients with episodic migraine without aura (at
least 4 attacks per month of moderate-severe intensity; Group 1) and
18 patients with chronic migraine (no drug abuse; Group 2) were treat-
ed with levetiracetam 500 mg/day for 5 days, increased to 1000 mg/day
in two administrations, after 5 days. Number of days with
headache/month, accompanying symptoms (mild-moderate vs severe),
use of symptomatic drugs for migraine attacks (number of drugs), and
side effects of levetiracetam were recorded at baseline and at the end
of the 3-month treatment period in both groups.
Results One patient in Group 1 did not complete the study because of
intolerable side effects (somnolence and asthenia). Patients in Group 1
reported a mean reduction in the number of days/month with headache
from 8.4 at baseline to 4.1. In Group 2, 12 patients were nolonger clas-
sified as chronic (from 23.8 to 10.3 days/month, mean values), four
patients had an improvement of their chronic headache (from 23.8 to
16.2 days/month, mean values) and two had no improvement at the end
of the treatment period. Severe accompanying symptoms became mild-
moderate in 83% of patients in Group 1 and in 62% of patients in
Group 2. Drug intake for acute attacks per month changed from 12.3 at
baseline to 5.2 drugs in Group 1 and from 32 to 13 drugs in Group 2.
Side effects were somnolence (6 patients - 5 patients), asthenia (4 and
3), postural instability (2 and 0) in Groups 1 and 2, respectively.
Conclusions This study confirms the role of levetiracetam as a poten-
tial preventive treatment for migraine.
COMBINED NEUROMUSCULAR RELAXING AND SHIATSU
TREATMENT INTEGRATED WITH MELATONIN IN TEN-
SION-TYPE HEADACHE
A. Lera, M. Bernardini
Headache Centre DSM Giulianova, ASL Teramo, Teramo, Italy; 
e-mail: antonio.lera@aslteramo.it
Objective The aim of this study was to evaluate a combined neuro-
muscular relaxing and Shiatsu programme integrated with melatonin in
the treatment of tension-type headache. We tried to consider a possible
positive role of physical activity in reducing the frequency and intensi-
ty of headache attacks and, in particular, in decreasing activity limita-
tions at a working, social and family level, and therefore, to evaluate
the overall improvement in the patients’ quality of life.
Patients and methods Before enrolment in the study, 20 middle-aged
female subjects underwent psychodiagnostic evaluation with the fol-
lowing scales: MIDAS, MSQOL, MQoLQ, HIT, and MSQ. We utilised
the MIDAS scale in this study because it is an objective measure of the
severity of a headache attack; it specifies the level of inability and is
suitable for identifying the appropriate therapy on the basis of the sever-
ity level of each patient. MIDAS scores for our patients were between
6 and 10, which indicated no need for pharmacological therapy, exclud-
ing headaches with mild (level 1) and severe inability (levels 3–4). 
The study group, consisting of 10 females aged 35 – 60 years, under-
went combined neuromuscular, relaxing and shiatsu treatment every
week, integrated with melatonin retard formulation, 1 tablet per day,
for the entire length of the study. For the combined treatment there was
a successive prolongation phase: at first, every 15 days for an addi-
tional three months, then every month for a further three months. A
control group of the same number of subjects did not carry out any
treatment programme. At the end of nine months, both the study and
control groups underwent another psychodiagnostic evaluation.
Results Comparison of the MIDAS scores between the first and last
evaluations showed a decrease of six points in 10% of cases, five points
in 20%, four points in 15%, two points in 25%, with no change in 30%
of cases in the study group. No statistical difference was observed in the
comparison of the same group of MIDAS scores in the control group,
indicating a positive result only for the combined neuromuscular relax-
ing and Shiatsu programme integrated with melatonin. 
Conclusions On the basis of our results, we can assert that in the study
group, which underwent combined neuromuscular relaxing and Shiatsu
treatment integrated with Melatonin retard formulation, the quality of
life as evaluated by the MIDAS scale was improved significantly. This
combination programme seems to have a positive role in reducing the
frequency of headache attacks and in alleviating their severity.
EFFECTS OF DENTAL MALOCCLUSION CORRECTION ON
PAIN FROM CHRONIC TENSION-TYPE HEADACHE
L. Di Ianni, E. Tafuri, A. Fabrizio, A. Savini, G. Sidonio, G. Affaitati,
R. Lerza, P. de Bigontina, A. Mezzetti, M.A. Giamberardino
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Introduction Dental malocclusion is a very frequent finding in
patients with chronic tension-type headache. The aim of this study was
to investigate how malocclusion contributes to both the subjective
(number and intensity of attacks) and objective (pain thresholds in
muscles of the cervical and upper shoulder regions) painful sympto-
matology of this type of headache.
Methods Twenty-five patients (18 women and 7 men, aged 18–36 years)
were studied. They had been suffering from chronic tension-type
headache for at least 1 year prior to examination (diagnosis performed
according to IHS criteria) and also presented dental malocclusion. Their
headache pain was located in the occipital, parietotemporal and, in 11
cases, also fronto-orbital regions, bilaterally. In all of them pain thresh-
olds to electrical stimulation were measured bilaterally in the trapezius,
sternocleidomastoid and splenius muscles before and 30 days after appli-
cation of the bite to correct dental malocclusion. Measurements were
performed in the pain-free interval. Number and maximal intensity (VAS
scale) of headache attacks were also recorded in the month of treatment
and compared with those relative to the 30 days preceding treatment.
Results Before treatment, pain thresholds in all muscles were signifi-
cantly lower when compared to thresholds recorded in corresponding
sites of 20 non-headache sufferers (p<0.001) (hyperalgesia). In the
month of application of the bite there was a significant reduction in the
number of headache attacks (p<0.003) but not of their peak intensity;
pain thresholds on day 30 were still lower than normal (p<0.05) but
significantly increased with respect to pre-treatment values (p<0.008
for trapezius, p<0.004 for sternocleidomastoid, p<0.007 for splenius).
A significant linear correlation was found between the decrease in
headache pain and the increase in threshold (p<0.01).
Conclusions In patients with chronic tension-type headache, dental
malocclusion contributes directly to the triggering of the painful
attacks, probably through sensitization of muscles of the cervical/upper
shoulder regions.
EFFICACY OF A WORKPLACE COGNITIVE AND PHYSICAL
PROGRAMME ON PSYCHOSOMATIC SYMPTOMS IN A
WORKING COMMUNITY WITH HEADACHE, NECK AND
SHOULDER PAIN: A LONGITUDINAL CONTROLLED STUDY
1F. Mongini, 1E. Rota, 2G. Ciccone, 2C. Galassi, 1L. Ferrero, 1A. Ugolini
1Headache-Facial Pain Section, Department of Clinical
Pathophysiology, University of Turin, Turin, Italy; 2Unit of Cancer
Epidemiology, San Giovanni Battista Hospital, Turin, Italy; e-mail:
franco.mongini@unito.it
Objective Our purpose was to examine the effect of a workplace cogni-
tive programme on psychosomatic symptoms in a working community.
Materials and methods Three hundred and eighty-four employees of
the city of Turin, whose working activities involved public contact (reg-
istry and tax office), were divided into two groups: study group (n=192)
and controls (n=192). In all subjects data regarding headache, neck and
shoulder pain, if present, were collected in a standardized fashion. Each
subject underwent a physical examination and muscle palpation of per-
icranial and cervical muscles. The presence of 28 symptoms, mainly
psychosomatic in nature, (such as colitis, gastritis, swallowing difficul-
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ties, digestive difficulties, phobias, sleep disorders, palpitations, dizzi-
ness, cramps, etc.) were also assessed. These items that belong to those
generally investigated when taking a medical history showed in previ-
ous studies a significantly higher prevalence in pain patients in respect
to a normal population. An instruction programme was then adminis-
tered to the study group: it consisted of brief shoulder and neck exer-
cises, a relaxation exercise and instructions on how to reduce hyper-
function of the craniofacial and cervical muscles during the day. After
six months, all subjects were re-examined in the same way as at base-
line and the presence of psychosomatic symptoms was assessed again.
In the two groups, the difference between the data at baseline and those
at the end was calculated and the data compared (Student’s test).
Results In the study group, the mean amount of psychosomatic symp-
toms decreased significantly (p=0.002) from baseline (7.27±5.19 SD) to
the end (5.73±4.77 SD). In the control group no significant difference
was observed (baseline: 6.65±5.07 SD; end: 6.55±4.93 SD; p=0.78).
Discussion The data demonstrate that the administration of a simple
cognitive instruction programme can significantly decrease psychoso-
matic symptoms in a working community. This finding, in contrast,
may be the direct consequence of the cognitive programme, or may be
partially due to the beneficial effects of such programme on the
headache, neck and shoulder pain in the study population.
Conclusions A cognitive instruction programme can significantly
reduce the presence of psychosomatic symptoms in extensive popula-
tion samples.
EFFECTIVENESS OF AN INTEGRATED APPROACH IN THE
PROPHYLACTIC TREATMENT OF CHRONIC TENSION-
TYPE HEADACHE
1,2,3B. Ciccone, 1,2,3G. Griso, 1,2,3S. Lenzuolo
1Headache Clinic, Medicine of the Future, Acerra, Naples, Italy;
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Introduction Retrospective study of patients from our clinics, suffering
from chronic tension-type headache (CTTH), diagnosed in accordance
with the criteria of the ICHD-II classification, code 2.3 (OMS G44.2).
Objective The purpose of this study was to demonstrate the effectiveness
of an integrated pharmacological and non pharmacological approach
compared with an approach that was exclusively pharmacological.
Materials and methods We selected 14 patients suffering from CTTH,
14 F, mean age 33 years (range 15–59)±14.1 years, who used an inte-
grated prophylactic therapy, compared with 14 patients suffering from
CTTC, 1 M and 13 F, mean age 33 years (range 13–50)±11.7 years,
treated solely with medication. The study was carried out over a period
lasting from 60 to 180 days. The patients using the integrated approach
received daily medication in addition to a weekly session of relational
systemic psychotherapy consisting of individual and familial meetings
(7 patients) or osteopathic treatment consisting of craniosacral therapy
and visceral manipulation (7 patients). The patients in the control group
(14) underwent only daily pharmacological prophylactic treatment.
The clinical diary regarding the headache of each patient was reviewed
to determine the number of crises per month and to monitor the per-
centage decrease of the crises.
Results The patient group following the pharmacological prophy-
laxis had only an average decrease of 64% in the number of
headaches per month.
The patient group using the integrated approach with weekly psy-
chotherapy had an average decrease of 88%, while the patients who
underwent craniosacral/visceral manipulation treatment had an average
decrease of 92%. Comparison of the two treatments indicated a statis-
tically significant decrease (p<0.005).
Discussion and conclusions The integrated approach in patients with
CTTH is more effective than the pharmacological approach alone, as it
affects treatment motivation, therapeutic reliability, compliance and
the consequent improvement of quality of life.
RATIONAL EMOTIVE BEHAVIOUR THERAPHY (REBT) IN
TENSION HEADACHE
1A. Mascaro, 1I. Salvaggio, 1E. Adducci, 1S. Barbi, 1L. Zappia, 
2G. Di Trapani
1Department of Anaesthesiology and Intensive Care and 2Department
of Neurology, Catholic University Medical School, Rome, Italy; 
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Introduction During the last few years, many studies have demonstrat-
ed how an emotional condition can influence pain. This aspect is espe-
cially evident for headache, in which the connection between emotion-
ality, pain, intensity and frequency is very important. In the Centre for
Pathophysiology and Pain Therapy of the Catholic University Medical
School of Rome, we studied a Rational Emotive Behaviour Therapy
(REBT) that underscores the importance of patients’ cognitive process-
es in the genesis and feeding of emotive and behavioural disturbances.
Materials and methods From September 2004 to April 2006, after
informed consent, we studied 60 patients (35 females and 25 males,
mean age 35 years). Their tension headaches (ICHD-II criteria, 2004)
were bilateral with occipital localization, without aura, vomiting, pho-
tophobia and phonophobia; they had eight crises per month and visual
analogue scale (VAS) score=7.
Their clinical history, objective and neurological examinations exclud-
ed a secondary headache. We had an indepth conversation with each
patient, and we noticed that everyone was depressed or anxious or hos-
tile; we gave them some forms to fill out and a headache diary to com-
plete before and after the start of therapy. They were divided into two
randomised groups of 30 patients. The first group was treated with cog-
nitive, emotional and behavioural techniques; the second group was
treated with pharmacological therapy with amitriptyline 30 mg/day,
alprazolam 0.25 mg/day and celecoxib 200 mg, if needed. They were
treated for 6 months.
Results In the first group, treated with cognitive psychotherapy, VAS
decreased from 7 to 3, the crises decreased from 8 to 2, and the emo-
tional condition improved with a reduction of depression, anxiety and
hostility. In the second group, treated with pharmacological therapy,
VAS decreased from 7 to 2, and the crises decreased from 8 to 3.
Conclusions From our results we observed that patients treated with
cognitive psychotherapy showed improvement in VAS scores and their
emotional condition, and reduction in the number of montly crises,
while patients treated with pharmacological therapy also had improved
VAS scores and reduction in the number of crises, but with no modifi-
cations of their emotional condition.
GYMNASTIC-PHYSICAL ACTIVITY: PERFECT SHAPE
FUNCTION IN MIGRAINE AND CLUSTER HEADACHE
1A. Lera, 1M. Bernardini, 2C. Germani
1Headache Centre DSM Giulianova, ASL Teramo, Teramo, Italy;
2Institute of Experimental Research for Motor Sciences Life Quality
Project, S. Benedetto del Tronto, Ascoli Piceno, Italy; e-mail:
antonio.lera@aslteramo.it
Objective The aim of this study was to evaluate the effects of a pro-
gramme of gymnastic-physical activity (Perfect Shape System) on the
quality of life in a group of subjects suffering from migraine and clus-
ter headache. We tried to consider a possible positive role of physical
activity in reducing the frequency and intensity of headache attacks
and, in particular, in decreasing inability at a working, social and fam-
ily level, and therefore, improving overall the patients’ quality of life.
Patients and methods Before enrolment in the study, forty subjects
suffering from primary headaches (30 with migraine and 10 with clus-
ter headache) underwent clinical evaluation with the following scales:
MIDAS, MSQOL, MQoLQ, HIT, and MSQ. We utilised the MIDAS
scale in this study since it is an instrument which objectively measures
the severity of a headache attack; it specifies the inability level and is
suitable for identifying the appropriate therapy on the basis of the
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severity level of each patient. MIDAS scores for our patient group
were between 6 and 10, which indicated no need for pharmacological
antimigraine therapy, excluding headaches causing mild (level 1) and
severe inability (levels 3–4). 
The study group consisted of 20 females aged 35–60 years, who under-
went gymnastic-physical activity through the methodical Perfect Shape
System, which lasted two months, followed by further activities for an
additional six months. A control group of equal number of subjects did
not carry out any gymnastic-physical programme at all. At the end of
eight months, all 40 patients of both the study and control groups,
underwent another clinical evaluation.
Results Comparison of the MIDAS scores between the first and last
evaluations showed a decrease of seven points in 5% of cases, six
points in 5%, five points in 15%, three points in 10%, one point in
20%, with no change in 45% of cases for the subjects who practised
Perfect Shape. No statistical difference was observed in the compari-
son of the same group of MIDAS scores in the control group, indicat-
ing a positive result only for the patients who followed the Perfect
Shape programme. 
Conclusions On the basis of our results, we can assert that in the study
group, which followed the Perfect Shape System, the quality of life as
evaluated by the MIDAS scale improved, although in a different way,
with reduction in negative social, working and family effects. This is
in marked contrast to the control group, who showed no improvement
in quality of life parameters. Gymnastic-physical activity and, in par-
ticular, the Perfect Shape programme, seem to contribute in a positive
way to reducing the frequency of headache attacks and to alleviating
their severity. However, there were no relevant changes in terms of
quality of life parameters between the different forms of primary
headaches.
USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE
BY PATIENTS WITH CLUSTER HEADACHE: RESULTS OF A
MULTI-CENTRE HEADACHE CLINIC SURVEY
1,2P. Rossi, 3P. Torelli, 1C. Di Lorenzo, 2G. Sances, 3G.C. Manzoni, 
2C. Tassorelli, 2,4G. Nappi
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The use of complementary and alternative medicine (CAM) in cluster
headache (CH) is a phenomenon about which little is known. This
study was undertaken to evaluate the rates, pattern, satisfaction and
presence of predictors of CAM use in a clinical population of patients
with CH. One hundred CH patients attending three headache clinics
were asked to undergo a physician-administered structured interview
designed to gather information on CAM use.
Past use of CAM therapies was reported by 29% of the patients sur-
veyed, with 10% having used CAM in the previous year. Only 8% of
the therapies used were perceived as effective, while a partial effec-
tiveness was reported in 28% of CAM treatments. The most common
source of recommendation of CAM was a friend or relative (54%).
Approximately 62% of CAM users had not informed their medical
doctors of their CAM use. The most common reason for deciding to try
a CAM therapy was that it offered a “potential improvement of
headache” (44.8%). Univariate analysis showed that CAM users had a
higher income, had a higher lifetime number of conventional medical
doctor visits, had consulted more headache specialists, had a higher
number of CH attacks per year with disease and had a significantly
higher proportion of chronic CH vs episodic CH. A binary logistic
regression analysis was performed and two variables remained as sig-
nificant predictors of CAM use, the income level (OR=5.7, 95%
CI=1.6–9.1, p=0.01), and the number of attacks per year with disease
(OR=3.08, 95% CI=1.64–6.7, p<0.0001).
Our findings suggest that CH patients, in their need of and quest for
care, seek and explore both conventional and CAM approaches, even
if only a very small minority finds them satisfactory. Conventional
MDs and CAM practitioners should be made aware of this redefinition
of the role of modern biomedicine, given that they are in a unique posi-
tion to provide patients with help and guidance.
STANDARDIZED APPROACH TO PATIENTS WITH MIGRAINE
IN A HEART-BRAIN CENTRE: 6-MONTH EXPERIENCE
1G. Dalla Volta, 1B. Troianiello, 1S. Griffini, 1P. Zavarise, 2A. Pezzini,
3A.M. Lanzone, 3R. Albero, 4M. Guindani
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Cardiology Clinic, Brescia, Italy; 4Clinical Institute S. Anna, Brescia,
Italy; e-mail: dalla@numerica.it
Background Because a pathogenic relationship between patent fora-
men ovale (PFO) and migraine with aura is assumed, percutaneous clo-
sure of PFO has been recently proposed as an effective treatment.
However, definitive criteria to identify a priori migraine patients who
will benefit from PFO closure and those whose migraine will not be
influenced by this treatment are lacking. We propose the standardized
approach to these patients in use at the Heart-Brain Centre of the
Clinica St Rocco of Ome, Brescia.
Methods During a 6-month period, 120 patients with migraine with
aura, 48 patients with migraine without aura, and 18 patients with clus-
ter headache were evaluated. All subjects underwent a contrast-
enhanced transcranial Doppler (TCD) investigation to detect the pres-
ence/absence of PFO. This was diagnosed in 62.5% of cases with aura,
37.5% of those without aura, and 38.8% of cluster headache. In the case
of a positive finding, a standardized work-up including brain MRI,
thrombophilic tests (proteins C and S, antithrombin III, APCR, anti-
phospholipid antibodies, total plasma homocysteine, vitamin B12 and
folate levels, G1691A polymorphism of factor V, G20210A polymor-
phism of factor II, C677T polymorphism of MTHFR), ultrasound eval-
uation of the deep veins of the legs and the carotid-vertebral arteries was
carried out. Transesophageal echocardiography was performed in cases
of PFO-positivity with curtain effect, MRI evidence of ischemic lesions
(MRI+), or evidence of a prothrombotic state (T+). This allowed the
identification of co-existent atrial septal aneurysm (ASA).
Discussion and conlusions Based on these findings, PFO closure can
be considered in cases with co-existent ASA when at least one of the
following conditions is present: curtain pattern on TCD, MRI+, or T+.
It can also be considered in those cases without co-existent ASA in
which MRI+ or T+ are present.
Although the management of PFO in patients with migraine is still a
matter of debate, the proposed standardized approach can be of help in
selecting patients who will benefit from percutaneous closure in clini-
cal practice.
EPIDURAL BLOOD PATCH IN THE TRENDELENBURG POSI-
TION TO TREAT HEADACHE BY SPONTANEOUS CSF LEAK
1E. Ferrante, 2I. Arpino, 1A. Citterio, 2R. Wetzl, 2A. Savino, 1R. Sterzi
1Neurosciences and 2Emergency Departments, Niguarda Cà Granda
Hospital, Milan, Italy; e-mail: enricoferrante@libero.it
Background Spontaneous intracranial hypotension (SIH) generally
results from spontaneous spinal CSF leakage [1]. Treatment is usually
conservative but epidural blood patch (EBP) has emerged as the most
important nonsurgical treatment for SCSFL [2].
Objective To evaluate the efficacy of epidural blood patch (EBP) in
the Trendelenburg position in the treatment of headache by sponta-
neous CSF leakage (SCSFL).
Materials and methods We observed 30 patients with SCSFL
between 1992 and 2005. Eleven patients (6 women and 5 men; age
range 31–66 years, mean age 40) received EBP. All patches were per-
formed in the lumbar region, using 15 to 30 mL (mean 23 mL) of autol-
303
ogous blood. All patients mantained a 30° Trendelenburg position dur-
ing the procedure and for 24 hours after the procedure. Follow-up
ranged from 6 months to 2 years.
Results All patients had orthostatic headaches. Other manifestations
were nausea, vomiting, mild neck stiffness, tinnitus, blurred vision,
diplopia and bilateral upper limb numbness. CT myelography, spinal
MRI or brain MRI or radionuclide cisternography showed CSF leak-
age sites in 6 out of 11 patients; 2 sites were at the cervical level, the
others at the lumbar level. In 10 out of 11 patients, brain MRI
showed diffuse pachymeningeal gadolinium enhancement (neu-
roimaging of intracranial hypotension). All patients failed an initial
conservative treatment, which consisted of bed rest and hydration,
over a period of 1 to 13 months. All treated patients became asymp-
tomatic, 1 responded only after 3 EBP, and 1 had a residual mild
headache during the Valsalva manoeuvre for 2 months. Until now,
none has had a relapse.
Discussion and conclusions Our data confirm the efficacy of EBP in
the SCSFL headache and suggest also the importance of a prolonged
Trendelenburg position especially when the leak site is at the cervical
level and the autologous blood patch in the lumbar region is performed.
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HEADACHE IN CHILDHOOD AND ADOLESCENCE I
CLIMATIC VARIATIONS AND MIGRAINE IN CHILDHOOD
D. Moscato, M.I. Peracchi
Headache Centre, Saint Charles Hospital, Rome, Italy; e-mail:
dmoscat@tin.it
The incidence of migraine in childhood has increased in recent years.
Up to now that increase has been attributed to the worsening of
childern’s conditions: the job of both parents, the long distance to
school, the high number of separations, divorces etc. [1, 2].
Regardless, the environmental situation, unexpected climatic varia-
tions, and elevated levels of pollutants, may also have had a specific
influence on migraine.
We tried to estimate the influence of these factors in a group of 120 chil-
dren (72 F, 48 M, age range 5–17 years) affected by migraine without
aura (n=112) and migraine with aura (n=8), assessed from 1995 to 2005.
For these patients the headache triggers were evaluated (Table 1).
No significant variations were found in the percentage of stress as a
trigger factor, whereas the number and percentages of patients refer-
ring atmospheric variations and solar exposure as a triggering factor
increased over time.
These preliminary data need to be confirmed by further studies.
Among triggers examined, solar exposure as a controllable trigger
should be avoided or limited to reduce its influence in inducing
migraine attacks.
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TENSION-TYPE HEADACHE IN CHILDREN
A. Forabosco, T. Grandi, M. Malavasi
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Introduction Tension-type headache is a common problem among
children in primary school. Dental malocclusion can often be the cause
of this form of primary headache [1].
Materials and methods Twenty schoolchildren who had already
received a diagnosis of primary headache treated with analgesic sub-
stances came to our clinic. An orthodontic evaluation and
orthopanoramic X-ray film were performed. All patients were found
suffering from malocclusion. Limitation of the functional mandible’s
movements, teeth abrasions, and hypertrophy of the mandibular eleva-
tor muscles were present. To treat muscular problems originating from
the stomatognathic system, an occlusal splint was performed. Intensity
[using a graphic rating scale (GRS)] and frequency (daily, weekly,
monthly) of headache before treatment (T0), after one month (T1),
after three months (T2) and after six months (T3) were recorded.
Wilcoxon test was applied for statistical evaluation.
Results All patients showed a considerable reduction of their symp-
toms. A significant improvement of the intensity and the frequency of
headache attacks was registered after treatment (p<0.0001).
Discussion and conclusions The high occurrence of malocclusion in
the subjects with tension-type headache seems to play an important
role in the genesis of headache. At present, the treatment for patients
who suffer from these disorders has increasingly required the need for
a collaborative team approach. An orthodontic treatment should be
suggested, both for an improvement of the headache and the function-
al aspects, but the results may not be significant before 2 years [2]. An
application of a plate bite, without any drug therapy, can be the treat-
ment of choice to reduce the symptomatology in children suffering
from tension-type headaches.
References
1. Moscato D, Banaudi E, Zino G (2000) Malocclusion affect the
occurrence of child headache: preliminary data. Cephalalgia 20:285
2. Henrikson T (1999) Temporomandibular disorders and mandibular
function in relation to Class II malocclusion and orthodontic treat-
ment. A controlled, prospective and longitudinal study. Swed J Dent
Suppl 134:1–144
HEADACHE AND QUALITY OF LIFE IN A CHILD AND ADO-
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Introduction Up to 10% of children between the ages of 5 and 15 have
migraines [1], while an even higher number of adolescents have
migraines [2].
The primary aim of this study was to evaluate the quality of life in
young patients, using the PED-MIDAS, the QLH-Y Questionnaire and
Table 1 Trigger Factors
1995 1997 1999 2001 2003 2005 Total
Emotional stress, % 90 90 80 90 100 70 83
Physical stress, % 50 30 30 40 60 30 40
Environment stress, % 70 80 90 50 90 60 73
Lights, % 50 40 60 30 70 40 48
Smell, % 40 20 40 60 30 40 33
Smoke, % 20 40 20 40 10 20 25
Food, % 20 20 20 10 00 10 15
Climatic Variations, % 40 50 60 60 70 80 60
Solar exposure, % 10 20 40 60 90 70 48
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Children’s Depression Inventory (CDI) scales. A secondary end-point
was to examine the changes in clinical picture and diagnoses related to
headache treatment.
Methods and patients The study included 70 patients (32 F, 38M; age
range: 8–15 years, mean age 12.34±1.91 years) visited in the Modena
Headache Centre between January 2002 and June 2004. At the initial
visit, each patient underwent complete history-taking and general and
neurological examinations in the presence of a parent. A second fol-
low-up visit was performed in the period January-June 2005;
headaches were diagnosed according to the International Headache
Society criteria (ICHD-II).
Questionnaire At the follow-up visit, the patients were asked to check
MIDAS, QLH-Y and CDI Questionnaires in the presence of a trained
doctor. They were urged to express their own judgements, but they
could ask a parent for advice.
Results All 70 patients completed the study. Mean illness duration was
44.31 months. Forty-two patients had migraine without aura, 10 had
migraine with aura, 18 had tension-type headache (16 with episodic
tension-type headache (ETTH) and 2 with chronic tension-type
headache (CTTH)). Sixty-eight out of 70 patients confirmed the first
diagnosis. The frequency of headache was related to the degree of dis-
ability, while the intensity was moderate-severe in almost all patients
in spite of disability scores.
Pathological values found in Children’s Depression Inventory (CDI) at
the follow-up visit showed that almost 50% of patients had a bad percep-
tion of themselves with devaluation and often with feelings of despera-
tion, and thus referred disobedience, asthenia and a negative body image.
According to the QLH-Y data, our patients seemed to experience
stress, fatigue and somatic symptoms. The most used drug for
headache attack was acetaminophen.
Discussion The results of this study suggest that the prevalence of
migraine without aura and ETTH decreases with increasing age.
Optimal care for children and adolescents with headache can be realized
with collaboration among primary care practitioners and headache spe-
cialists; behavioural treatment is a foundation for provision of such care.
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HEADACHE AND EPILEPSY IN CHILDREN
E. Tozzi, R. Savini, I. Florio, A. Di Fonzo, B. Giobbi
Paediatric Clinic, University of L’Aquila, L’Aquila, Italy; e-mail:
etozzi@univaq.it
Introduction The association between headaches and epileptic
seizures is a well-known phenomenon. The headache could be peri-
ictal and interictal, in 50% of epileptic patients [1]. The incidence of
interictal headache is not clear, but many authors have shown that the
incidence of interictal migraine headache was significantly higher in
patients with migraine-like postictal headache [2].
Materials and methods Forty-three children aged 4–18 years, 22
males and 21 females, affected by epilepsy and suffering from
headache, were studied in order to verify the correlation between peri-
ictal and interictal headache. Headache was diagnosed according to
ICHD-II criteria, and epilepsy according to ILAE 1989 criteria.
Epilepsy was diagnosed as: Benign focal epilepsy with vertex spikes
and waves (BVSWE) in 9 children; reflex photosensitive epilepsy in 11
children, occipital epilepsy in 5 children, juvenile myoclonic epilepsy
in 4 children, and generalized epilepsy in 12 children.
The headache diagnosis was: migraine without aura (MO) in 18 chil-
dren, migraine with aura (MA) in 4 children, tension-type headache
(TTH) in 4 children, migraine-like and tension-type like headache in 6
children, and stabbing headache in 5 children.
Results In 20 children, the headache started before epilepsy began and
in 5 children after epilepsy began. In 26 children, the diseases were
contemporary. There was no correlation between the region of EEG
anomalies and the side of pain. Only 3 children, suffering from
BVSWE, and 5, suffering from generalized epilepsy, showed headache
in the vertex region.
In 11 children (25%), there was a temporal relationship between
headache and epilepsy. In 4 patients with seizures while sleeping, the
headache occurred upon awakening, in 3 children with occipital epilep-
sy the headache was postictal, and in 4 children with photosensitive
epilepsy the headache was preictal and was triggered by photic stimuli
(TV, play station).
The preictal headache was defined by children as stabbing, the postic-
tal headache as migraine-like.
Conclusions Migrainous-like headache is prevalent among epileptic
children during the peri-ictal and interictal periods. In fact, migraine-
like headache was found in 50% of patients with photosensitive epilep-
sy and migraine in 100% of children with rolandic epilepsy.
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Introduction Early-onset benign occipital seizure susceptibility syn-
drome or the “Panayiotopoulos type” of childhood epilepsy with occip-
ital paroxysms (PS) is a partial form of epilepsy that occurs in 13% of
children aged 3–6 years with one or more non-febrile seizures [1].
Although many authors have studied the relationship between
headache and PS, there do not seem to be any clear results [1].
Aim The aim of our study was to determine the relationship between
migraine and PS in childhood and the prevalence of family history of
migraine and epilepsy in patients with PS.
Patients and methods This was a retrospective study conducted at the
Child and Adolescent Neuropsychiatry Unit of our University
Hospital, in patients recruited between 1999 and 2006, diagnosed as PS
on the basis of the ILAE Task Force on Classification and Terminology
criteria. Anamnestic, clinical, and instrumental data were collected to
clear the semiology and the frequency of the seizures. All patients
underwent a video-EEG during wake and sleep cycles with HP and
ILS, and a brain MRI. All patients were given the specific record for
headache in children and adolescent patients of the Italian Child and
Adolescent Neuropsychiatry Society Group. The diagnosis of migraine
was based on the criteria of The International Classification of
Headache Disorders, 2nd edition (ICHD-II).
Migraine prevalence in children with PS and in their families was com-
pared with a member of the general population of the same age group.
Results We evaluated 20 patients with PS, 11 males and 9 females,
mean age at the end of follow-up=8.5 years, range 4 to 14 years.
Among these, 7/20 (35%) had migraine (six migraine without aura and
one with visual aura). Regarding family history: 13/20 cases (65%)
were positive for migraine, 5/20 (25%) for epilepsy, 4/20 (20%) for
both, and 4/20 for febrile seizures.
All children with migraine also had a family history of migraine. The
headache usually started in the same year in 2/7 cases (29%) or after
the diagnosis of epilepsy in 5/7 (71%).
Conclusions So far, no study has showed a clear relationship between
a family history of migraine and PS. In particular, Panayiotopoulos says
“there is no family history of similar disorders of benign childhood
seizure susceptibility, epilepsies or migraine” in children with PS [2].
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To our knowledge, this is the first retrospective study to report a preva-
lence of 65% for migraine, 25% for epilepsy, and 20% for both in fam-
ily members of affected children. PS and migraine are probably genet-
ically determined. Our study supports the hypothesis of a clinical con-
tinuum between migraine and epilepsy, particularly PS that share sim-
ilar characteristics and a familial spectrum.
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HEADACHE AND CARDIO-EMBOLIC STROKE: THE IMPOR-
TANCE OF CLINICAL SUSPICION. REPORT OF A PAEDI-
ATRIC CASE
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A 14-year-old boy, with an underlying history of asymptomatic
ostium secundum atrial septal defect and a family history negative
for vascular diseases or coagulation disorders, was admitted to the
emergency department of a general hospital because of a severe
headache and visual disturbance that began during a school exami-
nation. As brain CT scan and fundoscopic examination were normal,
he was dismissed with the diagnosis of migraine with aura and
symptomatic therapy. Twelve hours later for the persistence of the
same complaints, he was newly admitted: physical examination
showed right homonymous hemianopsia and a systolic ejection
murmur, but no other abnormalities. EEG showed bioelectric abnor-
malities on the left temporal and occipital regions and magnetic res-
onance imaging revealed acute left occipital infarction and normal
head and neck vessels. He was then transferred to our tertiary care
paediatric hospital; in the following days his clinical conditions
were stable. An expanded investigation for an underlying prothrom-
botic tendency showed increased plasma homocysteine (29 micro-
mol/L) and homozygosity for the methylenetetrahydrofolate reduc-
tase gene C677C>T polymorphism. Anticoagulant therapy, folic
acid and vitamin B12 supplementation was given and the 6-month
follow-up was uneventful: right temporal hemianopsia persisted.
Atrial septal defect was subsequently closed via percutaneous
approach.
Arterial ischemic stroke is being increasingly diagnosed and recog-
nized in childhood. Recognition of clinical stroke may be difficult, par-
ticularly in infants and young children. Ischemic events are usually
suspected when a child presents with abrupt onset of a hemiparesis but
the initial symptom can be a common complaint, such as isolated
headache and/or subtle and difficult to recognize focal sensory deficits
or visual disturbances.
A detailed history focused on the most frequent risk factors, such as
congenital thrombophilic states, cardiac diseases, infections, trauma
and sickle cell anemia, represents the initial screening for the diagno-
sis of paediatric stroke since multiple risk factors commonly coexist in
individual patients [1]. As demonstrated by our case report, magnetic
resonance is the imaging modality of choice to confirm that an acute
ischemic event has occurred and to determine the extent and location
of acute cerebral injury, the patency of major neck and intracranial
arteries and relative cerebral perfusion.
It is crucial to increase clinician awareness of stroke also in children as
clinical suspicion can reduce the time lag to diagnosis and to appropri-
ate treatment of this disease [2].
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HEADACHE IN ADOLESCENTS: SYMBOLIC MEANING
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Introduction Primary headaches can present occasional and nonspe-
cific anatomical and/or functional anomalies, but although they do not
have an aetiological and pathophysiological role in producing painful
attacks, they can influence the symptomatic course through the sym-
bolic meaning that they have for the patients and their family. We pre-
sent and analyse three cases of adolescents with these characteristics.
Case 1: A twelve-year-old boy with a story of migraine-type attacks
occurring every weekend for the last three months; brain MRI showed
a pineal cyst and for this reason he underwent neurosurgical consulta-
tion and another MRI with gadolinium; during the clinical evaluation,
migraine appeared the day before every examination and afterward, he
was migraine-free for long periods.
Case 2: An eleven-year-old boy suffering from tension-type headache
and depressive symptoms: his father was operated on for cerebral
aneurysm, the boy’s EEG showed positive occipital sharp waves,
evoked by all IPS frequencies; undergoing MRI, which was normal,
and clinical interviews regarding the family’s fears, in the last two
years, the boy nolonger suffered from headache.
Case 3: A fourteen-year-old girl presented with very frequent and severe
migraine-type attacks for about two months; she had been wearing an
orthodontic appliance for over two years. The decision to remove the
orthodontic appliance resulted in the disappearance of the headache.
Discussion The nonspecific anomalies, considered as symbols,
found in these three clinical cases are “dumb elements” [1], but they
represent an important meaning in the patients’ inner psychic life
and may induce the manifestation of some developmental emotion-
al problems. In the first case, pineal cyst may represent a need of
dependence in the relationship between the patient and his busy fam-
ily and help him to receive attention and be listened to. In the sec-
ond case, the abnormal EEG and the father’s history of cerebral
aneurysm produced in the boy an identity problem with a father who
was always absent. The clinical and psychological therapy and nor-
mal brain MRI examination disintegrated the “symbol” with the dis-
appearance of the headache. In the third case, the relationship with
a very perfectionist mother resulted in the onset of migraine-type
attacks. The removal of the orthodontic appliance allowed the
patient to become independent without being forced to accept a self-
image that the mother imposed.
Conclusions The three cases, with their different data and life events,
confirm that nonspecific signs need attention, because their symbolic
meaning may be significant and influence the course of pain.
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Introduction A strong association has been observed between
migraine and psychiatric problems such as depression and anxiety.
Objective The aim of this study was to describe the premorbid state of
migraine in children by using a structured questionnaire, designed to
obtain standardized reports of children’s behavioural problems and
capabilities, as observed by parents.
Subjects and methods Thirty subjects with migraine and 30 healthy
subjects were enrolled in a case-control study. Using the Child
Behaviour CheckList (CBCL), ratings were obtained for maternal
memories of the past for two age periods (0–3 years and 4–6 years) and
for the present state (7–16 years). The CBCL scores of the migraine
group (MG) were compared to those of the control group (CG) for the
three periods. A longitudinal analysis was performed to evaluate the
evolution of psychopathology, by comparing the CBCL scores of the
MG in the three age periods.
Results In the 7–16 year group, children of the MG had significantly
higher mean CBCL scores – i.e., nearer to the clinical threshold – than
those of the CG in several scales: total problems (p<0.01), internaliz-
ing (p<0.001), somatic (p<0.001), anxious/depressive (p<0.01),
thoughts (p<0.05) and attention problems (p<0.01). At 4–6 years, sig-
nificantly higher scores between the MG and the CG were found in the
total problems scale (p<0.001), internalizing (p<0.001), somatic
(p<0.001), anxious/depressive (p<0.001), attention (p<0.01), social
problems (p<0.01) and withdrawn (p<0.05). At 0–3 years, significant-
ly higher scores between the MG and the CG were found in the total
problems scale (p<0.01), internalizing (p<0.05), somatic (p<0.001),
and anxious/depressive (p<0.01). In a longitudinal perspective we did
not demonstrate statistically significant differences between 7–16 and
4–6 year age periods. Comparing the age periods of 4–6 years and 0–3
years, significant differences were found in total problems (p<0.01),
internalizing (p<0.001), somatic (p<0.01) and also in externalizing
(p<0.01) and aggressive syndrome scale (p<0.01), but not in the anx-
ious/depressive scale.
Discussion Our study suggests the association between migraine,
depression and anxiety during childhood and adolescence. The inter-
nalizing component (depression and anxiety) may represent a persis-
tent factor that feeds the migraine. The demonstration of an internaliz-
ing score in a headache patient, by means of the CBCL, could be of the
utmost importance to prevent migraine from becoming chronic.
Conclusions Migraine may begin during childhood/adolescence with a
symptomatology, which may have its roots in previous behavioural
problems. Even if they rarely reach the clinical threshold with the
CBCL questionnaire, children who develop migraine are different from
healthy children for the higher rate of behavioural problems..Migraine
could be considered the expression of a previous vulnerability.
HEADACHE: WHAT DO CHILD AND MOTHER WANT FROM
THEIR PHYSICIAN?
V. Raieli, G. La Franca, M. La Vecchia, E. Pandolfi, D. Puma, 
D. Ragusa, R. Ceraulo, M. Eliseo
Division of Child Neuropsychiatry “L. Biondo”, Ingrassia Hospital,
A.U.S.L. 6, Palermo, Italy; e-mail: vinzi.raielk@inwind.it
Introduction To establish a good “strategic compliance” between the
doctor, and the young headache patient and the patient’s family, it is
important to know what the mothers or the children want from paedia-
tricians and neurologists.
Objective The aim of this study was focused on child’s and mother’s
expectations regarding the diagnostic and therapeutic approaches from
the paediatrician and neuropsychiatrist. Moreover, we wanted to know
the doctors’ opinions.
Methods We selected 100 consecutive children older than 10 years
with primary headaches, admitted for the first time to our department.
A questionnaire was administered individually to the children and to all
100 mothers before the visit. It had several multiple choice questions
about the child’s and mother’s fears, their expectations and opinions
regarding medical visits, and symptomatic and prophylactic therapy. A
short questionnaire was also administered to 50 paediatricians, having
common characteristics previously selected with a questionnaire.
Results The principal reasons for seeking consultation were because
the pain was more frequent and severe (72% and 24%, respectively).
The mothers’ main questions concerned the reasons for headache
and reassurance about their fears (respectively 61% and 46%). Fifty-
six percent of the mothers thought that the use of symptomatic drugs
was necessary, while only 33% thought that preventive drugs were
useful and 34% of mothers feared that they cause dependency or
serious side effects. The children wanted to be mainly reassured
(60%), know the reasons for the headache (45%), and if they would
suffer from headaches in adulthood (36%) (mothers and doctors only
4%). The children thought that the use of symptomatic drugs was
necessary (68%) and that preventive therapy was useful (61%).
Fifty-eight percent of doctors believed that the principal reasons for
the consultation were the frequency (58%) and intensity (26%) of
headache, and the fear of tumour (24%). In the opinion of the doc-
tors, the more important mothers’ questions concerned reassurance
about their fears and the prescription of medical diagnostic tests
(60% and 50%, respectively). They believed that the children want-
ed to be mainly reassured, cured and to have explanations about the
headache (62%, 38% and 44%, respectively). The paediatricians
(90%) believed that symptomatic drugs were necessary and that pre-
ventive therapies were useful (74%).
Discussion These data suggest that the child’s and mother’s main con-
cerns pertain to explanation of headache and reassurance about it, while
the prescriptions of drugs or medical tests are not believed necessary.
The doctors’ opinions seem in part similar. The main differences regard-
ed the use of diagnostic tests and pharmacological therapies and the
question about headache progression into adulthood made by children.
HEADACHE IN CHILDHOOD AND ADOLESCENCE II
DEPRESSION AND CHRONIC HEADACHE IN CHILDHOOD
AND ADOLESCENCE 
M.A. Tavoni, O. Papa, E. Cesaroni, C. Cardinali
Riuniti University Hospitals, Paediatric Neurology Department,
Children’s Hospital “G. Salesi”, Ancona, Italy; e-mail: npisalesi@
ao-salesi.marche.it
Introduction The role and importance of the psychiatric and psycho-
logical aspects in determining and influencing the insurgence and evo-
lution of chronic headache in childhood and adolescence have been the
object of numerous studies. Many authors have tried to analyse the pos-
sible correlations between depression, anxiety disorders and headache.
Objective The aim of our study was to analyse the possible correla-
tions between chronic headache and depressive disorder with or with-
out anxiety disorder.
Materials and methods Sixty-two children (38 males, 24 female;
mean age 9 years, 5 months; range: 6–13 years) were enrolled from
493 subjects seen from 2003 to 2005 among the outpatients from the
Departments of Headache and Psychology of the “Ospedali Riuniti “G.
Salesi” Children’s Hospital. Fifty-two patients affected with chronic
headache were subdivided into 3 subgroups: chronic tension-type
headache (CTTH), chronic daily headache (CDH) and mixed headache
(CTTH and headache); 10 patients affected from episodic tension-type
headache (ETTH) were identified according to IHCD-II 2004 criteria.
The patients under investigation were evaluated by the juvenile
headache flow-chart (haematological, clinicians, neurophysiologic and
neuroimaging exams) and by a psychodiagnostic protocol that we use
in our centre.
Results Following the DSM IV criteria the subjects of the two groups
were subdivided in:
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- Depressive Disorder Mood (DDM);
- Depressive Disorder Mood + generalized anxiety disorder
(DDM+GAD);
- Depressive Disorder Mood + Learning Disorder Not Otherwise
Specified (DDM+LDNOS);
- Depressive Disorder Mood + Oppositional Defiant Disorder
(DDM+ODD);
- Generalized Anxiety Disorder (GAD);
- Others.
The clinical history of the 62 subjects was negative for psychiatric
pathologies or history of acute traumatic events. Depressive disorders
were comorbid in 37/52 of the subjects with chronic headache, primar-
ily represented by DDM + GAD (30/52). The GAD subgroup was pre-
sent in 13/52 chronic headache patients and in 3/10 ETTH patients.
Male gender was more represented, but female gender prevailed in the
group of chronic headache with DDM + GAD. Chronic headache was
not associated with DDM + ODD but was present in 2 patients affect-
ed by ETTH. The prevalence of depressive disorders was greater in
chronic headache (71.1%) than in ETTH (40%). DDM was more fre-
quently associated with GAD (57.6%).
Conclusions Chronic headache is frequently associated with depressive
and anxiety disorders both in adult and paediatric patients. Headache can
be the first symptom silently expressed by the depressed child.
Therefore, headache that evolves to acquire chronic characteristics
must be carefully evaluated because it could mask important psychi-
atric disorders that should be considered for the diagnosis and therapy.
PSYCHOLOGICAL ASSESSMENT OF MIGRAINOUS CHIL-
DREN AND ADOLESCENTS
1P. Mariotti, 1R. Chiera, 1F. Perrino, 1S. Staccioli, 1P. De Rose, 
2C. Vollono, 2G. Della Marca, 3G.M. Vecchio, 4C. Pastorelli
1Unit of Child Neuropsychiatry, and 2Unit of Neurology, Policlinic “A.
Gemelli”, Catholic University, Rome, Italy; 3Faculty of Psychology 2,
and 4Department of Psychology, University of Rome, “La Sapienza”,
Rome, Italy; e-mail: pmariotti@rm.unicatt.it
Introduction General population studies suggest a non-casual asso-
ciation between headache, major depression and anxiety disorders
[1]. The consensus is that migraine sufferers are at higher risk of
depression, bipolar disorders and certain forms of anxiety – this is
particularly true for migraine with aura. Co-morbidity with psychi-
atric disorders has also been described for chronic tension-type
headache and for chronic daily headache [2]. The data available in
the literature are still relatively scarce and contradictory, especially
for young people.
Objective The aim of our study was to evaluate the association
between headache and different psychological characteristics, includ-
ing tendencies toward depression, perfectionism and repressed aggres-
sion, in children and adolescents.
Methods Clinically referred children and adolescents (n=45) 8–18
years of age, subdivided into two age groups: 8–10 years (n=19) and
11–18 years (n=26), suffering from primary headache according to the
diagnostic criteria of the International Headache Society, 16 with
migraine with aura (MA), 29 with migraine without aura (MO), and
1 021 normal controls without headache (NC), were assessed using the
Parent Child Behaviour Checklist (CBCL), the Youth Self Report
(YSR), Children’s Depression Inventory (CDI), and the Centre for
Epidemiological Studies Depression Scales (CESD).
Results According to the literature, our data confirm that children with
migraine have significantly higher levels of total internalizing, partic-
ularly for somatic complaints with respect to those without headache.
Attention has been focused on the YSR interview, a self-report assess-
ment, never used until now in this field, that was administered to ado-
lescents aged 11–18 years. Both thought problems and internalizing
symptoms in migraineurs have been demonstrated by YSR. We wish to
emphasize that thought problems are not significantly different
between the general paediatric population and migraineurs in some
studies in parental reports (CBCL). Moreover, CDI (self rating of
depression) results show statistically significant differences between
migraine and non-headache paediatric subjects, in comparison with
other studies published in the literature.
Conclusions We stress the importance of the use of YSR for the assess-
ment of psychological traits in migrainous children and adolescents,
because generally parents have been found to be poorer at internaliz-
ing symptoms than the child, and parents’ reports of CBCL may under-
estimate anxiety symptoms. This holds not only for the diagnostic and
therapeutic implications but also for the prognostic aspects.
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EFFICACY OF TOPIRAMATE IN PAEDIATRIC MIGRAINE
PROPHYLAXIS
1E. Conicella, 2F. Vigevano, 2M. Valeriani
1DEA and 2Headache Centre, Division of Neurology, “Bambino Gesù”
Paediatric Hospital, IRCCS, Rome, Italy; e-mail: m.valeriani@tiscali.it
Introduction Migraine is the most common type of primary headache
in childhood and often hampers common daily routines.
Objective The aim of our study was to investigate the efficacy and
safety of topiramate in the prevention of paediatric migraine.
Materials and methods Twenty-five children (mean age 11 years,
range 5–16 years; 10 females, 15 males) were recruited. In 23 children,
migraine without aura was diagnosed according to the International
Headache Society classification (ICHD-II, 2004), while the remaining
2 children had migraine with aura. 
Results Before treatment, our patients showed 8±5.7 (mean±stan-
dard deviation) pain attacks per month. The children received a
mean topiramate dose of 1.3 mg/kg/day, ranging from 0.5 to 1.8
mg/kg/day, for a period of 3.2±1.2 months. Treatment was effective
(reduction in attack number ≥ 50%) in 19 out of 25 children (76%).
In particular, 3 patients (12%) became free from migraine episodes.
One patient (4%) interrupted the treatment for adverse side effects
(excessive drowsiness). Seven patients in which the initial treatment
was effective underwent a worsening in migraine frequency after
topiramate interruption and needed a further treatment after 4.3±2.8
months. Six patients had a reduction in the frequency of pain
episodes greater than 75%, while in one child the therapy was inef-
fective. Two patients had a third treatment at 3 and 4 months, respec-
tively, after interrupting the second topiramate cycle. The therapy
was ineffective in both patients. Adverse events were observed in 6
out of 25 children (24%). They consisted of drowsiness (3 patients),
anxiety (1 patient), weight loss (2 patients), and behavioural distur-
bances (3 patients).
Discussion and conclusions Our results suggest that topiramate is a
useful and safe tool in paediatric migraine prophylaxis. Even low doses
allowed us to control migraine in most of our paediatric patients, thus
improving their quality of life.
MELATONIN, 3 MG, IS EFFECTIVE FOR MIGRAINE PRE-
VENTION ALSO IN SCHOOL-AGED PATIENTS
M. Carotenuto, F. Tagliente, F. Ruju, A. Pascotto
Department of Developmental Neurology and Psychiatry, Second
University of Naples, Naples, Italy; e-mail: marco.carotenuto@unina2.it
Background Hypothalamic dysfunction may be present in migraine
and in circadian periodicity of headache attacks, more specifically, the
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suprachiasmatic nucleus and melatonin have been suggested to play a
role in the pathogenesis [1]. Altered melatonin levels have been found
in cluster headache, migraine with and without aura, menstrual
migraine, and chronic migraine. Melatonin may have many metabolic
effects, such as anti-inflammatory effects (melatonin and indomethacin
share similar chemical structure), reducing the up-regulation of proin-
flammatory cytokines, and inhibiting nitric oxide synthase activity and
dopamine release. Melatonin administration is thus a possible candi-
date for migraine prevention [2].
Objective The aim of this open trial was to test the hypothesis of the
potential effectiveness of melatonin for migraine prophylaxis also in
school-aged children.
Patients and methods We performed an open-label trial of mela-
tonin, 3 mg, for migraine prevention. Twenty-three patients (11 M, 12
F) aged 6–15 years (mean 12.8 years, SD±1.38) with episodic
migraine with or without aura according to ICHD-II 2004 criteria,
were screened for the baseline period. All patients started prophylac-
tic treatment with melatonin, 3 mg, 10 minutes before bedtime for 3
months. A complete clinical interview and examination as well neu-
rophysiological recordings (wake and sleep EEG) were performed
for each patient. Study participants experienced between two and six
attacks per month. Exclusion criteria included the presence of sleep
disorders, as confirmed by the mothers of all subjects who filled out
the Sleep Disturbances Scale for Children [SDSC]. The SDSC is a
sleep questionnaire that consists of 26 items subdivided into 6 sleep
disorder subscales according to American Sleep Disorders
Association criteria: DIMS (disorders in initiating and maintaining
sleep), SDB (sleep disordered breathing), DA (disorders of arousal),
SWTD (sleep-wake transition disorders), DES (disorders of exces-
sive somnolence), SHY (sleep hyperhydrosis).
Results Twenty out of 23 patients completed the study (86.95%). That
patients (85%, 17/20) who completed the study had at least a 50%
reduction in intensity and frequency of headache attacks. Nobody
reported an increase in headache frequency. Complete (100%)
response was achieved in 12 patients (60%) and no adverse effects
were recorded.
Conclusions There is increasing evidence to indicate that the hypo-
thalamus plays a major role in the pathophysiology of several of the
primary headache disorders, such as migraine, and hypnic headache
[1, 2]. Melatonin, an indole compound derived from serotonin, was
reported safe and effective in adult patients [2], but no data were
available for school-aged children. This is an original study to assess
melatonin, 3 mg, for prophylactic treatment of headache also in
childhood.
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EMERGENCY IN CHILDREN. BRAIN TUMOUR: CLINICAL
CASES
D. Moscato, M.I. Peracchi
Headache Centre, Saint Charles Hospital, IDI Rome, Rome, Italy; 
e-mail: dmoscat@tin.it
Brain tumours in children, due to their characteristic of slow invasive-
ness and easy infiltration in the nervous tissue, tend to give specific
symptoms only when they are of a large size.
We present a few cases which came to our attention last year.
Martina is an eight-year-old girl, who came to us due to widespread
headache that started three years before. She was a child presenting a
conflicting separation since the age of 3, which she responded to ini-
tially with hyporexia; she was anxious, agitated, very attached to her
mother. The symptoms seemed linked more to the psychological
aspects. Neurological testing was negative. During Day Hospital she
presented an intense headache crisis, which receded without treatment
with NSAIDs. A MRI identified a new formation in the posterior cra-
nial fossa. Surgical intervention revealed an adenoma, 2 months later,
the headache had fully disappeared.
Giorgia is 13-years old, suffering from migraine for two years. Her
parents are separated, and she is very attached to her mother, who still
sleeps with her. In the past 3 months, she has suffered from sleep dis-
turbances, sleep talking and frequent accentuated awakenings, with
intense headache almost daily during the same period. Vomiting with
coughing was present, but the girl had been following a diet for one
month. The neurological examination was negative. Emotional ten-
sion was evident in the family. During hospitalisation she experi-
enced slight difficulty in climbing the stairs. TAC shows a 6 cm
hypodense formation in the temporal occipital area. Surgical resec-
tion of a grade 1 medulloblastoma was followed by one cycle of
chemotherapy.
Gianluca is 5-years old, and had been complaining of intense cluster
headache for a few months after occipital cranial trauma without
loss of consciousness. The headache worsened overtime with an
increase in severity. During Day Hospital, 10 days after the trauma,
he complained of diffuse violent headache, with crying.
Neurological examination was negative except for slight fluctua-
tions on Romberg. CT showed a voluminous new formation in the
posterior cranial fossa. He was transferred to the Neurosurgery Unit,
where neurological signs began with vomiting, drowsiness, dysme-
tria, and dysarthria. Surgical resection of a Grade 4 medulloblastoma
was followed by chemotherapy and radiotherapy. The following year
he relapsed, and was operated on again, followed by another cycle
of chemotherapy, but his condition worsened. Sixteen months after
being diagnosed, he died.
Conclusions In the cases presented above the specific symptoms of
intracranial pressure, vomiting and papilledema stasis without
headache, as well as those linked to focality, are absent. Also, the neu-
rological examination yielded no precise indications. The same psy-
chological characteristics could have led to the wrong diagnosis.
Observation overtime of the reactions of children to headache during
Day Hospital had led us to select neuroimaging testing, which led to
the diagnosis. Therefore, we believe that a child with an important
headache must always be visited during a crisis.
HEADACHE IN A PAEDIATRIC EMERGENCY DEPARTMENT
1,2L. Calistri, 2M. Guasti, 1,2C. Scalas, 2M. de Luca, 3F. Festini, 
2S. Masi, 2F. Mannelli
1Headache Centre for Childhood and Adolescence, Paediatric
Neurological Clinic, 2Emergency Department, 3Department of
Paediatrics, University Hospital “A. Meyer”, Florence, Italy; e-mail:
l.calistri@meyer.it
Objective The aim of this study was to determine the prevalence of
headache as the chief complaint in patients presenting to a paediatric
Emergency Department (ED), to assess its characteristics, to study the
spectrum of primary and secondary headache diagnoses and to analyze
the diagnostic tests and the treatment applied. 
Methods We retrospectively analysed the clinical records of patients
presenting to the ED of the Paediatric Hospital A. Meyer of Florence,
Italy with the chief complaint of headache from January 1, 2005, to
June 30, 2005. All the patients underwent a clinical evaluation/case
history, and if necessary also had laboratory or imaging tests per-
formed. The ED records were searched for triage color code, age, gen-
der, location of pain, associated symptoms, case history, physical
examination (particularly neurological examination), assessments and
specialists’ visits, therapy at the ED, time spent at the ED, and outcome
(discharge – hospitalization – further assessments at the Centre for
Headache in Childhood and Adolescence).
Nosology was established using the International Classification for
Headache Disorders ICDH-II.
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Results Two hundred and twenty-three clinical records (2.2% of the
total number of visits) concerning 203 patients (121 male and 82
female) were analyzed; the average age was 8.9 years (range
2.1–17.1 years). Primary headaches (migraine and tension-type
headache) were recorded in 33 subjects (16.2%): 10 patients with
migraine without aura, 10 subjects with probable migraine, 2 cases
of migraine with aura, 2 subjects with benign paroxysmal vertigo of
childhood; from all the tension-type headaches, 7 were frequent, 4
infrequent, and 1 chronic. Three subjects were found to have both
migraine and tension headache (mixed headache). Secondary
headaches were mainly attributed to infections in 80 subjects
(39.4%) and to sinusitis in 16 patients (7.9%). Five cases (2.5%)
were found to be attributed to serious neurological conditions: 1
cerebral empyema, 1 cerebral ischemia, 1 intracranial haemorrhage
attributed to arteriovenous malformation, and 2 patients with
intracranial hypertension already treated at the Oncohematology
Centre for cerebral expansive lesion. After the clinical assess-
ment/case history, 144 patients (64.6%) were discharged from the
ED without further tests. Radiological and laboratory assessments
and/or specialists’ examinations were performed in 35.4% of the
patients. Neuroimaging tests were performed in 27 patients of whom
44.4% presented pathological results. Eighteen subjects (8.8%) were
hospitalized.
Conclusions This study confirms that headaches in the paediatric ED
have different etiology. In 57 subjects (28.1%) headache could not be
classified. Future prospective studies may be useful to assess the fol-
low-up in this group of patients.
HEMORRHAGIC PROLACTINOMA IN THE PAEDIATRIC AGE
GROUP: TWO CASES WITH DIFFERENT CLINICAL PRE-
SENTATION
1P.A. Battistella, 2G.B. Pozzan, 1A. Permunian, 1I. Toldo, 1S. Sartori,
3R. Faggin
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Introduction Pituitary juvenile adenomas are rare (2% to 6% of all
supratentorial neoplasms) and prolactinoma is the prevalent tumour [1].
Subjects and methods We present two paediatric cases of hemor-
rhagic prolactinoma. The first case was a 7-year-old boy, with an
acute left-sided visual loss (acuity 1/10 and fundus oculi was nor-
mal). Visual evoked potentials (VEPs) showed increased latencies
after left eye stimulation. MRI showed a suprasellar lesion hyperin-
tense on T1- and T2-weighted images without enhancement and bor-
dering on the optic chiasm. The serum prolactin was 439 µg/L (nor-
mal <15), with decreased cortisol (88 nmol/L, normal >198) and
ACTH (3 ng/L, normal >10). After steroidal therapy, visual acuity
improved (8–9/10). He then underwent a transphenoidal complete
resection of the prolactinoma and subsequently presented panhypopi-
tuitarism. The second case was a 17-year-old girl with a three-month
last recurrent, moderate, biparietal headache associated with photo-
phobia, especially in the afternoon. In the previous year an oligomen-
orrhea was treated with hormonal therapy. This treatment was
stopped because of headache, which was unresponsive to pill with-
drawal. Neurological examination was normal. MRI showed a T1-
and T2-weighted hyperintense suprasellar lesion without enhance-
ment. As in the first case, these findings indicated a hemorrhagic
pituitary macroadenoma. The serum prolactin was 203 µg/L (normal
<25). Visual acuity and visual field were normal. After the surgical
resection, she needed substitutive hormonal therapy and, since then,
she has never suffered from headache.
Discussion and conclusions Hemorrhagic prolactinomas are rare in
children [2]. Patients usually present headache and visual field deficits.
Other findings are gynecomastia and puberal delay in males and amen-
orrhea in females. The cases reported are characterized by peculiar
clinical features. The first one presented a pituitary apoplexy, rare in
paediatric age group, and a monolateral visual loss with VEPs abnor-
malities consistent with an optic neuritis. In the second one, instead,
the oligomenorrhea although of a mild pattern was the key-sign for the
correct diagnosis of a secondary headache.
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SPHENOID MUCOCELE IN CHILDREN: DESCRIPTION OF
TWO CASES
P.A. Battistella, L. Bianchin, S. Sartori, A.M. Laverda, R. Faggin, 
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Introduction Sphenoid mucoceles are very rare, benign cystic lesions
(1% of all localizations) [1, 2]. Due to connection with several struc-
tures (cavernous sinuses, pituitary, orbits and choanas), clinical mani-
festations can be extremely variable.
Subjects and methods Case 1: An 8-year-old male presented with a
subcontinuous mild-moderate, bifrontal, pressing headache on awak-
ening for seven days, without any associated symptoms. On the eighth
day, an acute left III cranial nerve palsy with exotropia, ptosis and
mydriasis appeared. CT scan showed an erosion of the parasellar struc-
tures and MRI revealed a lesion of the sphenoid body, hyperintense on
both T1-T2 sequences without enhancement. The maxillofacial CT
scan confirmed the sphenoid body lesion. Hormone levels, visual fields
and acuity were normal. After ten days the headache spontaneously
disappeared, but nerve deficit persisted. Endoscopic trans-sphenoidal
permitted total removal of the lesion, followed by histological confir-
mation and complete resolution of the third cranial nerve palsy. He was
asymptomatic at the 5-year follow-up.
Case 2: A 12-year-old male since last year suffered from recurrent, pul-
sating, weekly headache, localized to the right frontal-ocular region,
with photophobia and phonophobia, sometimes nausea, rarely vomit-
ing and responsive to NSAIDs. His father suffered from migraine with-
out aura. During the recent admission to our hospital the neurological
examination was negative. Brain MRI showed hypointense signal on
T1 and hyperintense signal on T2 in the left part of the sphenoid sinus,
with partial involvement of the ipsilateral ethmoid and maxillary sinus-
es. Sinus CT confirmed a left-sphenoidal mucocele, with indication for
an endoscopic sphenoidotomy.
Discussion and conclusions The first case presented a painful oph-
thalmoplegia which, considering only the clinical picture, could be
diagnosed as ophthalmoplegic migraine (ICHD-II, 2004 classification,
point 13.17), a very rare condition in young patients, or as Tolosa–Hunt
syndrome (ICHD-II, 2004, point 13.16), which also presents with sim-
ilar features, although with unilateral pain. Neuroimaging, however,
documented a rare benign pathology.
In the second case, the patient may be affected by migraine without
aura, considering the family history, the type and stability of attacks
over time, the resolution with vomiting after the attacks, and the later-
alization of the sphenoid lesion, contralateral to the pain. Thus the dis-
covery of a sphenoid mucocele at an early stage can be considered
accidental, even if this diagnosis is confirmed after surgery.
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TWO CLINICAL CASES OF RED EAR SYNDROME (RES)
CONNECTED WITH HEADHACHE
C. Termine, C. Pintacrona, G.A. Magro, A. Vecchio
Multispecialty Paediatric University Department, Maternity Unit,
AUSL 6, Child Neuropsychiatry Division, Palermo, Italy; e-mail:
chiaratermine@virgilio.it
Introduction The Red Ear Syndrome (RES) is characterized by sud-
den events when the patient feels a kind of uneasiness (sometimes a
real painful sensation) mainly localized in one ear, which becomes
red and warm. Sometimes it happens in a spontaneus way, some-
times it is caused by triggers, like touching the ears, feeling warm or
cold, moving the neck, chewing, drinking, coughing or sneezing,
The first description of RES dates back to 1996 thanks to Lance [1]
who studied its characteristics in 12 patients, some of them having a
past of headache. More recently, Raieli et al. 2002) [2] discovered a
closer connection between RES and migraine in eight patients. Here,
we present two clinical cases that might confirm what is reported in
the recent literature. The first one concerns a little boy of 11 years
affected by an almost daily headache bilaterally localized to the
forehead, causing heaviness of variable intensity lasting about 30
minutes together with nausea, vertigo, phosphenes, pallor, perspira-
tion and hyporexia. The second case concerns a little boy of 7 years
who was observed because of a symptomatology of weekly
headaches, localized on the parietotemporal side, characterized by
pulsating, variable intensity, and lasting no more than 30 minutes. In
both cases, the headaches were accompanied by the reddening of a
single ear.
Materials and methods Before admittance a careful clinical history
was taken according to our protocol for headache diagnosis, and
through an accurate clinical and instrumental neurological examina-
tion, following the guidelines of the Italian Headache Society for the
Study of Headache (SISC).
Results This diagnostic approach allowed us to place the patients’
symptomatology in a context of headache connected with RES,
bypassing the difficulty in classifying the kind of headache they were
affected by, as often happens in patients of that age.
Conclusions Our experience is further proof of the observation made
by other authors regarding the connection between RES and headache
symptomatology. This suggests the possibility that RES, when present
in patients suffering from headache, is epidemiologically understated
at present, and the debate is still open on the possibility of including
RES in an unclassified category of headache disorders according to the
IHS classification.
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